Organic electroluminescent materials and devices

ABSTRACT

A compound of Formula (L A ) n -M-(L C ) m , wherein the ligand L A  is of Formula I, and the ligand L C  is selected from Formula I that is different than ligand L A , a monoanionic bidentate ligand, or a monoanionic monodentate ligand. M is a metal; and n is 1 or 2, and m is 0, 1 or 2. 
     
       
         
         
             
             
         
       
         
         
           
             Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B; 
             Z is selected from O or S; Z 1  is selected from a carbene C or N; and Z 2  is selected from C or N. Moreover, two adjacent ring carbons of Ring B will form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons, 
           
         
       
    
     
       
         
         
             
             
         
       
     
     Formula D, wherein X is selected from NR N , O, S, or Se; and R N  is selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl, and combinations thereof; and Y 1 , Y 2 , Y 3 , and Y 4  are independently CR Y1 , CR Y2 , CR Y3 , and CR Y4 , respectively, or N, and Ring D has no more than two nitrogen ring atoms. An OLED that includes a compound of the Formula I above in an organic layer is also described.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims priority under 35 U.S.C. § 119(e) to U.S. Provisional Application No. 62/681,741, filed Jun. 7, 2018, the entire contents of which are incorporated herein by reference.

FIELD

The present invention relates to compounds, and the use of the compounds as a host materials in electronic devices, e.g., an organic light emitting diode.

BACKGROUND

Opto-electronic devices that make use of organic materials are becoming increasingly desirable for a number of reasons. Many of the materials used to make such devices are relatively inexpensive, so organic opto-electronic devices have the potential for cost advantages over inorganic devices. In addition, the inherent properties of organic materials, such as their flexibility, may make them well suited for particular applications such as fabrication on a flexible substrate. Examples of organic opto-electronic devices include organic light emitting diodes/devices (OLEDs), organic phototransistors, organic photovoltaic cells, and organic photodetectors. For OLEDs, the organic materials may have performance advantages over conventional materials. For example, the wavelength at which an organic emissive layer emits light may generally be readily tuned with appropriate dopants.

OLEDs make use of thin organic films that emit light when voltage is applied across the device. OLEDs are becoming an increasingly interesting technology for use in applications such as flat panel displays, illumination, and backlighting. Several OLED materials and configurations are described in U.S. Pat. Nos. 5,844,363, 6,303,238, and 5,707,745, which are incorporated herein by reference in their entirety.

One application for phosphorescent emissive molecules is a full color display. Industry standards for such a display call for pixels adapted to emit particular colors, referred to as “saturated” colors. In particular, these standards call for saturated red, green, and blue pixels. Alternatively the OLED can be designed to emit white light. In conventional liquid crystal displays emission from a white backlight is filtered using absorption filters to produce red, green and blue emission. The same technique can also be used with OLEDs. The white OLED can be either a single EML device or a stack structure. Color may be measured using CIE coordinates, which are well known to the art.

One example of a green emissive molecule is tris(2-phenylpyridine) iridium, denoted Ir(ppy)₃, which has the following structure:

In this, and later figures herein, we depict the dative bond from nitrogen to metal (here, Ir) as a straight line.

As used herein, the term “organic” includes polymeric materials as well as small molecule organic materials that may be used to fabricate organic opto-electronic devices. “Small molecule” refers to any organic material that is not a polymer, and “small molecules” may actually be quite large. Small molecules may include repeat units in some circumstances. For example, using a long chain alkyl group as a substituent does not remove a molecule from the “small molecule” class. Small molecules may also be incorporated into polymers, for example as a pendent group on a polymer backbone or as a part of the backbone. Small molecules may also serve as the core moiety of a dendrimer, which consists of a series of chemical shells built on the core moiety. The core moiety of a dendrimer may be a fluorescent or phosphorescent small molecule emitter. A dendrimer may be a “small molecule,” and it is believed that all dendrimers currently used in the field of OLEDs are small molecules.

As used herein, “top” means furthest away from the substrate, while “bottom” means closest to the substrate. Where a first layer is described as “disposed over” a second layer, the first layer is disposed further away from substrate. There may be other layers between the first and second layer, unless it is specified that the first layer is “in contact with” the second layer. For example, a cathode may be described as “disposed over” an anode, even though there are various organic layers in between.

As used herein, “solution processable” means capable of being dissolved, dispersed, or transported in and/or deposited from a liquid medium, either in solution or suspension form.

A ligand may be referred to as “photoactive” when it is believed that the ligand directly contributes to the photoactive properties of an emissive material. A ligand may be referred to as “ancillary” when it is believed that the ligand does not contribute to the photoactive properties of an emissive material, although an ancillary ligand may alter the properties of a photoactive ligand.

As used herein, and as would be generally understood by one skilled in the art, a first “Highest Occupied Molecular Orbital” (HOMO) or “Lowest Unoccupied Molecular Orbital” (LUMO) energy level is “greater than” or “higher than” a second HOMO or LUMO energy level if the first energy level is closer to the vacuum energy level. Since ionization potentials (IP) are measured as a negative energy relative to a vacuum level, a higher HOMO energy level corresponds to an IP having a smaller absolute value (an IP that is less negative). Similarly, a higher LUMO energy level corresponds to an electron affinity (EA) having a smaller absolute value (an EA that is less negative). On a conventional energy level diagram, with the vacuum level at the top, the LUMO energy level of a material is higher than the HOMO energy level of the same material. A “higher” HOMO or LUMO energy level appears closer to the top of such a diagram than a “lower” HOMO or LUMO energy level.

As used herein, and as would be generally understood by one skilled in the art, a first work function is “greater than” or “higher than” a second work function if the first work function has a higher absolute value. Because work functions are generally measured as negative numbers relative to vacuum level, this means that a “higher” work function is more negative. On a conventional energy level diagram, with the vacuum level at the top, a “higher” work function is illustrated as further away from the vacuum level in the downward direction. Thus, the definitions of HOMO and LUMO energy levels follow a different convention than work functions.

More details on OLEDs, and the definitions described above, can be found in U.S. Pat. No. 7,279,704, which is incorporated herein by reference in its entirety.

SUMMARY

A compound of Formula (L_(A))_(n)-M-(L_(C))_(m), wherein the ligand L_(A) is of Formula I, and the ligand L_(C) is selected from Formula I that is different than ligand L_(A), a monoanionic bidentate ligand, or a monoanionic monodentate ligand. M is a metal; and n is 1 or 2, and m is 0, 1 or 2.

Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B;

Z is selected from O or S; Z¹ is selected from a carbene C or N; and Z² is selected from C or N;

R^(A) and R^(B) represent mono to the maximum allowable substitution, or no substitution; and each R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent groups of R^(A) or R^(B) can join to form a carbocyclic ring or a heterocyclic ring, which is optionally substituted; or optionally R^(A) or R^(B) can join with the ligand L_(C) to form a multidentate ligand.

Moreover, two adjacent ring carbons of Ring B will form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons,

Formula D, wherein X is selected from NR^(N), O, S, or Se; and R^(N) is selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl, and combinations thereof;

Y¹, Y², Y³, and Y⁴ are independently CR^(Y1), CR^(Y2), CR^(Y3), and CR^(Y4), respectively, or N, and Ring D has no more than two nitrogen ring atoms;

R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently selected from the group hydrogen, deuterium, fluorine, alkyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, acyl, ester, nitrile, isonitrile, sulfanyl, and combinations thereof; or any two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can join to form a fused 6-member ring, or a fused 5-member ring, each of which can be carbocyclic or heterocyclic, and aromatic or non-aromatic, each of which is optionally substituted.

An OLED that includes a compound of the Formula I above in an organic layer is also described.

A consumer product comprising an OLED that includes a compound of the Formula I above in an organic layer is also described.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows an organic light emitting device.

FIG. 2 shows an inverted organic light emitting device that does not have a separate electron transport layer.

DETAILED DESCRIPTION

Generally, an OLED comprises at least one organic layer disposed between and electrically connected to an anode and a cathode. When a current is applied, the anode injects holes and the cathode injects electrons into the organic layer(s). The injected holes and electrons each migrate toward the oppositely charged electrode. When an electron and hole localize on the same molecule, an “exciton,” which is a localized electron-hole pair having an excited energy state, is formed. Light is emitted when the exciton relaxes via a photoemissive mechanism. In some cases, the exciton may be localized on an excimer or an exciplex. Non-radiative mechanisms, such as thermal relaxation, may also occur, but are generally considered undesirable.

The initial OLEDs used emissive molecules that emitted light from their singlet states (“fluorescence”) as disclosed, for example, in U.S. Pat. No. 4,769,292, which is incorporated by reference in its entirety. Fluorescent emission generally occurs in a time frame of less than 10 nanoseconds.

More recently, OLEDs having emissive materials that emit light from triplet states (“phosphorescence”) have been demonstrated. Baldo et al., “Highly Efficient Phosphorescent Emission from Organic Electroluminescent Devices,” Nature, vol. 395, 151-154, 1998; (“Baldo-I”) and Baldo et al., “Very high-efficiency green organic light-emitting devices based on electrophosphorescence,” Appl. Phys. Lett., vol. 75, No. 3, 4-6 (1999) (“Baldo-II”), are incorporated by reference in their entireties. Phosphorescence is described in more detail in U.S. Pat. No. 7,279,704 at cols. 5-6, which are incorporated by reference.

FIG. 1 shows an organic light emitting device 100. The figures are not necessarily drawn to scale. Device 100 may include a substrate 110, an anode 115, a hole injection layer 120, a hole transport layer 125, an electron blocking layer 130, an emissive layer 135, a hole blocking layer 140, an electron transport layer 145, an electron injection layer 150, a protective layer 155, a cathode 160, and a barrier layer 170. Cathode 160 is a compound cathode having a first conductive layer 162 and a second conductive layer 164. Device 100 may be fabricated by depositing the layers described, in order. The properties and functions of these various layers, as well as example materials, are described in more detail in U.S. Pat. No. 7,279,704 at cols. 6-10, which are incorporated by reference.

More examples for each of these layers are available. For example, a flexible and transparent substrate-anode combination is disclosed in U.S. Pat. No. 5,844,363, which is incorporated by reference in its entirety. An example of a p-doped hole transport layer is m-MTDATA doped with F₄-TCNQ at a molar ratio of 50:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. Examples of emissive and host materials are disclosed in U.S. Pat. No. 6,303,238 to Thompson et al., which is incorporated by reference in its entirety. An example of an n-doped electron transport layer is BPhen doped with Li at a molar ratio of 1:1, as disclosed in U.S. Patent Application Publication No. 2003/0230980, which is incorporated by reference in its entirety. U.S. Pat. Nos. 5,703,436 and 5,707,745, which are incorporated by reference in their entireties, disclose examples of cathodes including compound cathodes having a thin layer of metal such as Mg:Ag with an overlying transparent, electrically-conductive, sputter-deposited ITO layer. The theory and use of blocking layers is described in more detail in U.S. Pat. No. 6,097,147 and U.S. Patent Application Publication No. 2003/0230980, which are incorporated by reference in their entireties. Examples of injection layers are provided in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety. A description of protective layers may be found in U.S. Patent Application Publication No. 2004/0174116, which is incorporated by reference in its entirety.

FIG. 2 shows an inverted OLED 200. The device includes a substrate 210, a cathode 215, an emissive layer 220, a hole transport layer 225, and an anode 230. Device 200 may be fabricated by depositing the layers described, in order. Because the most common OLED configuration has a cathode disposed over the anode, and device 200 has cathode 215 disposed under anode 230, device 200 may be referred to as an “inverted” OLED. Materials similar to those described with respect to device 100 may be used in the corresponding layers of device 200. FIG. 2 provides one example of how some layers may be omitted from the structure of device 100.

The simple layered structure illustrated in FIGS. 1 and 2 is provided by way of non-limiting example, and it is understood that embodiments of the invention may be used in connection with a wide variety of other structures. The specific materials and structures described are exemplary in nature, and other materials and structures may be used. Functional OLEDs may be achieved by combining the various layers described in different ways, or layers may be omitted entirely, based on design, performance, and cost factors. Other layers not specifically described may also be included. Materials other than those specifically described may be used. Although many of the examples provided herein describe various layers as comprising a single material, it is understood that combinations of materials, such as a mixture of host and dopant, or more generally a mixture, may be used. Also, the layers may have various sublayers. The names given to the various layers herein are not intended to be strictly limiting. For example, in device 200, hole transport layer 225 transports holes and injects holes into emissive layer 220, and may be described as a hole transport layer or a hole injection layer. In one embodiment, an OLED may be described as having an “organic layer” disposed between a cathode and an anode. This organic layer may comprise a single layer, or may further comprise multiple layers of different organic materials as described, for example, with respect to FIGS. 1 and 2.

Structures and materials not specifically described may also be used, such as OLEDs comprised of polymeric materials (PLEDs) such as disclosed in U.S. Pat. No. 5,247,190 to Friend et al., which is incorporated by reference in its entirety. By way of further example, OLEDs having a single organic layer may be used. OLEDs may be stacked, for example as described in U.S. Pat. No. 5,707,745 to Forrest et al, which is incorporated by reference in its entirety. The OLED structure may deviate from the simple layered structure illustrated in FIGS. 1 and 2. For example, the substrate may include an angled reflective surface to improve out-coupling, such as a mesa structure as described in U.S. Pat. No. 6,091,195 to Forrest et al., and/or a pit structure as described in U.S. Pat. No. 5,834,893 to Bulovic et al., which are incorporated by reference in their entireties.

Unless otherwise specified, any of the layers of the various embodiments may be deposited by any suitable method. For the organic layers, preferred methods include thermal evaporation, ink-jet, such as described in U.S. Pat. Nos. 6,013,982 and 6,087,196, which are incorporated by reference in their entireties, organic vapor phase deposition (OVPD), such as described in U.S. Pat. No. 6,337,102 to Forrest et al., which is incorporated by reference in its entirety, and deposition by organic vapor jet printing (OVJP), such as described in U.S. Pat. No. 7,431,968, which is incorporated by reference in its entirety. Other suitable deposition methods include spin coating and other solution based processes. Solution based processes are preferably carried out in nitrogen or an inert atmosphere. For the other layers, preferred methods include thermal evaporation. Preferred patterning methods include deposition through a mask, cold welding such as described in U.S. Pat. Nos. 6,294,398 and 6,468,819, which are incorporated by reference in their entireties, and patterning associated with some of the deposition methods such as ink-jet and organic vapor jet printing (OVJP). Other methods may also be used. The materials to be deposited may be modified to make them compatible with a particular deposition method. For example, substituents such as alkyl and aryl groups, branched or unbranched, and preferably containing at least 3 carbons, may be used in small molecules to enhance their ability to undergo solution processing. Substituents having 20 carbons or more may be used, and 3-20 carbons is a preferred range. Materials with asymmetric structures may have better solution processability than those having symmetric structures, because asymmetric materials may have a lower tendency to recrystallize. Dendrimer substituents may be used to enhance the ability of small molecules to undergo solution processing.

Devices fabricated in accordance with embodiments of the present invention may further optionally comprise a barrier layer. One purpose of the barrier layer is to protect the electrodes and organic layers from damaging exposure to harmful species in the environment including moisture, vapor and/or gases, etc. The barrier layer may be deposited over, under or next to a substrate, an electrode, or over any other parts of a device including an edge. The barrier layer may comprise a single layer, or multiple layers. The barrier layer may be formed by various known chemical vapor deposition techniques and may include compositions having a single phase as well as compositions having multiple phases. Any suitable material or combination of materials may be used for the barrier layer. The barrier layer may incorporate an inorganic or an organic compound or both. The preferred barrier layer comprises a mixture of a polymeric material and a non-polymeric material as described in U.S. Pat. No. 7,968,146, PCT Pat. Application Nos. PCT/US2007/023098 and PCT/US2009/042829, which are herein incorporated by reference in their entireties. To be considered a “mixture”, the aforesaid polymeric and non-polymeric materials comprising the barrier layer should be deposited under the same reaction conditions and/or at the same time. The weight ratio of polymeric to non-polymeric material may be in the range of 95:5 to 5:95. The polymeric material and the non-polymeric material may be created from the same precursor material. In one example, the mixture of a polymeric material and a non-polymeric material consists essentially of polymeric silicon and inorganic silicon.

Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of electronic component modules (or units) that can be incorporated into a variety of electronic products or intermediate components. Examples of such electronic products or intermediate components include display screens, lighting devices such as discrete light source devices or lighting panels, etc. that can be utilized by the end-user product manufacturers. Such electronic component modules can optionally include the driving electronics and/or power source(s). Devices fabricated in accordance with embodiments of the invention can be incorporated into a wide variety of consumer products that have one or more of the electronic component modules (or units) incorporated therein. A consumer product comprising an OLED that includes the compound of the present disclosure in the organic layer in the OLED is disclosed. Such consumer products would include any kind of products that include one or more light source(s) and/or one or more of some type of visual displays. Some examples of such consumer products include flat panel displays, curved displays, computer monitors, medical monitors, televisions, billboards, lights for interior or exterior illumination and/or signaling, heads-up displays, fully or partially transparent displays, flexible displays, rollable displays, foldable displays, stretchable displays, laser printers, telephones, mobile phones, tablets, phablets, personal digital assistants (PDAs), wearable devices, laptop computers, digital cameras, camcorders, viewfinders, micro-displays (displays that are less than 2 inches diagonal), 3-D displays, virtual reality or augmented reality displays, vehicles, video walls comprising multiple displays tiled together, theater or stadium screen, a light therapy device, and a sign. Various control mechanisms may be used to control devices fabricated in accordance with the present invention, including passive matrix and active matrix. Many of the devices are intended for use in a temperature range comfortable to humans, such as 18 degrees C. to 30 degrees C., and more preferably at room temperature (20-25 degrees C.), but could be used outside this temperature range, for example, from −40 degree C. to +80 degree C.

The materials and structures described herein may have applications in devices other than OLEDs. For example, other optoelectronic devices such as organic solar cells and organic photodetectors may employ the materials and structures. More generally, organic devices, such as organic transistors, may employ the materials and structures.

The terms “halo,” “halogen,” or “halide” as used interchangeably and refer to fluorine, chlorine, bromine, and iodine.

The term “acyl” refers to a substituted carbonyl radical (C(O)—R_(s)).

The term “ester” refers to a substituted oxycarbonyl (—O—C(O)—R_(s) or —C(O)—O—R_(s)) radical.

The term “ether” refers to an —OR, radical.

The terms “sulfanyl” or “thio-ether” are used interchangeably and refer to a —SR, radical.

The term “sulfinyl” refers to a —S(O)—R_(s) radical.

The term “sulfonyl” refers to a —SO₂—R_(s) radical.

The term “phosphino” refers to a —P(R)₃ radical, wherein each R_(s) can be same or different.

The term “silyl” refers to a —Si(R_(s))₃ radical, wherein each R can be same or different.

In each of the above, R can be hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, and combination thereof. Preferred R_(s) is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, and combination thereof.

The term “alkyl” refers to and includes both straight and branched chain alkyl radicals. Preferred alkyl groups are those containing from one to fifteen carbon atoms and includes methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 2,2-dimethylpropyl, and the like. Additionally, the alkyl group may be optionally substituted.

The term “cycloalkyl” refers to and includes monocyclic, polycyclic, and spiro alkyl radicals. Preferred cycloalkyl groups are those containing 3 to 12 ring carbon atoms and includes cyclopropyl, cyclopentyl, cyclohexyl, bicyclo[3.1.1]heptyl, spiro[4.5]decyl, spiro[5.5]undecyl, adamantyl, and the like. Additionally, the cycloalkyl group may be optionally substituted.

The terms “heteroalkyl” or “heterocycloalkyl” refer to an alkyl or a cycloalkyl radical, respectively, having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably, O, S or N. Additionally, the heteroalkyl or heterocycloalkyl group is optionally substituted.

The term “alkenyl” refers to and includes both straight and branched chain alkene radicals. Alkenyl groups are essentially alkyl groups that include at least one carbon-carbon double bond in the alkyl chain. Cycloalkenyl groups are essentially cycloalkyl groups that include at least one carbon-carbon double bond in the cycloalkyl ring. The term “heteroalkenyl” as used herein refers to an alkenyl radical having at least one carbon atom replaced by a heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably, O, S or N. Preferred alkenyl, cycloalkenyl, or heteroalkenyl groups are those containing two to fifteen carbon atoms. Additionally, the alkenyl, cycloalkenyl, or heteroalkenyl group is optionally substituted.

The term “alkynyl” refers to and includes both straight and branched chain alkyne radicals. Preferred alkynyl groups are those containing two to fifteen carbon atoms. Additionally, the alkynyl group is optionally substituted.

The terms “aralkyl” or “arylalkyl” are used interchangeably and refer to an alkyl group that is substituted with an aryl group. Additionally, the aralkyl group is optionally substituted.

The term “heterocyclic group” refers to and includes aromatic and non-aromatic cyclic radicals containing at least one heteroatom. Optionally the at least one heteroatom is selected from O, S, N, P, B, Si and Se, preferably, O, S or N. Hetero-aromatic cyclic radicals may be used interchangeably with heteroaryl. Preferred hetero-non-aromatic cyclic groups are those containing 3 to 7 ring atoms which includes at least one hetero atom, and includes cyclic amines such as morpholino, piperidino, pyrrolidino, and the like, and cyclic ethers/thio-ethers, such as tetrahydrofuran, tetrahydropyran, tetrahydrothiophene, and the like. Additionally, the heterocyclic group may be optionally substituted.

The term “aryl” refers to and includes both single-ring aromatic hydrocarbyl groups and polycyclic aromatic ring systems. The polycyclic rings may have two or more rings in which two carbons are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is an aromatic hydrocarbyl group, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. Preferred aryl groups are those containing six to thirty carbon atoms, preferably six to twenty carbon atoms, more preferably six to twelve carbon atoms. Especially preferred is an aryl group having six carbons, ten carbons or twelve carbons. Suitable aryl groups include phenyl, biphenyl, triphenyl, triphenylene, tetraphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene, preferably phenyl, biphenyl, triphenyl, triphenylene, fluorene, and naphthalene. Additionally, the aryl group may be optionally substituted.

The term “heteroaryl” refers to and includes both single-ring hetero-aromatic groups and polycyclic aromatic ring systems that include at least one heteroatom. The heteroatoms include, but are not limited to O, S, N, P, B, Si and Se. In many instances, O, S or N are the preferred heteroatoms. Hetero-single ring aromatic systems are preferably single rings with 5 or 6 ring atoms, and the ring can have from one to six heteroatoms. The hetero-polycyclic ring systems can have two or more rings in which two atoms are common to two adjoining rings (the rings are “fused”) wherein at least one of the rings is a heteroaryl, e.g., the other rings can be cycloalkyls, cycloalkenyls, aryl, heterocycles, and/or heteroaryls. The hetero-polycyclic aromatic ring systems can have from one to six heteroatoms per ring of the polycyclic aromatic ring system. Preferred heteroaryl groups are those containing three to thirty carbon atoms, preferably three to twenty carbon atoms, more preferably three to twelve carbon atoms. Suitable heteroaryl groups include dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine, preferably dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, triazine, benzimidazole, 1,2-azaborine, 1,3-azaborine, 1,4-azaborine, borazine, and aza-analogs thereof. Additionally, the heteroaryl group may be optionally substituted.

Of the aryl and heteroaryl groups listed above, the groups of triphenylene, naphthalene, anthracene, dibenzothiophene, dibenzofuran, dibenzoselenophene, carbazole, indolocarbazole, imidazole, pyridine, pyrazine, pyrimidine, triazine, and benzimidazole, and the respective aza-analogs of each thereof are of particular interest.

The terms alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aralkyl, heterocyclic group, aryl, and heteroaryl, as used herein, are independently unsubstituted or substituted with one or more general substituents.

In many instances, the general substituents are selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, cyclic amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In some instances, the preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.

In some instances, the preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, sulfanyl, and combinations thereof.

In yet other instances, the more preferred general substituents are selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, aryl, heteroaryl, and combinations thereof.

The terms “substituted” and “substitution” refer to a substituent other than H that is bonded to the relevant position, e.g., a carbon or nitrogen. For example, when R¹ represents mono-substitution, then one R¹ must be other than H (i.e., a substitution). Similarly, when R¹ represents di-substitution, then two of R¹ must be other than H. Similarly, when R¹ represents no substitution, R¹, for example, can be a hydrogen for available valencies of ring atoms, as in carbon atoms for benzene and the nitrogen atom in pyrrole, or simply represents nothing for ring atoms with fully filled valencies, e.g., the nitrogen atom in pyridine. The maximum number of substitutions possible in a ring structure will depend on the total number of available valencies in the ring atoms.

As used herein, “combinations thereof” indicates that one or more members of the applicable list are combined to form a known or chemically stable arrangement that one of ordinary skill in the art can envision from the applicable list. For example, an alkyl and deuterium can be combined to form a partial or fully deuterated alkyl group; a halogen and alkyl can be combined to form a halogenated alkyl substituent; and a halogen, alkyl, and aryl can be combined to form a halogenated arylalkyl. In one instance, the term substitution includes a combination of two to four of the listed groups. In another instance, the term substitution includes a combination of two to three groups. In yet another instance, the term substitution includes a combination of two groups. Preferred combinations of substituent groups are those that contain up to fifty atoms that are not hydrogen or deuterium, or those which include up to forty atoms that are not hydrogen or deuterium, or those that include up to thirty atoms that are not hydrogen or deuterium. In many instances, a preferred combination of substituent groups will include up to twenty atoms that are not hydrogen or deuterium.

The “aza” designation in the fragments described herein, i.e. aza-dibenzofuran, aza-dibenzothiophene, etc. means that one or more of the C—H groups in the respective aromatic ring can be replaced by a nitrogen atom, for example, and without any limitation, azatriphenylene encompasses both dibenzo[f,h]quinoxaline and dibenzo[f,h]quinoline. One of ordinary skill in the art can readily envision other nitrogen analogs of the aza-derivatives described above, and all such analogs are intended to be encompassed by the terms as set forth herein.

As used herein, “deuterium” refers to an isotope of hydrogen. Deuterated compounds can be readily prepared using methods known in the art. For example, U.S. Pat. No. 8,557,400, Patent Pub. No. WO 2006/095951, and U.S. Pat. Application Pub. No. US 2011/0037057, which are hereby incorporated by reference in their entireties, describe the making of deuterium-substituted organometallic complexes. Further reference is made to Ming Yan, et al., Tetrahedron 2015, 71, 1425-30 and Atzrodt et al., Angew. Chem. Int. Ed. (Reviews) 2007, 46, 7744-65, which are incorporated by reference in their entireties, describe the deuteration of the methylene hydrogens in benzyl amines and efficient pathways to replace aromatic ring hydrogens with deuterium, respectively.

It is to be understood that when a molecular fragment is described as being a substituent or otherwise attached to another moiety, its name may be written as if it were a fragment (e.g. phenyl, phenylene, naphthyl, dibenzofuryl) or as if it were the whole molecule (e.g. benzene, naphthalene, dibenzofuran). As used herein, these different ways of designating a substituent or attached fragment are considered to be equivalent.

In some instance, a pair of adjacent substituents can be optionally joined or fused into a ring. The preferred ring is a five, six, or seven-membered carbocyclic or heterocyclic ring, includes both instances where the portion of the ring formed by the pair of substituents is saturated and where the portion of the ring formed by the pair of substituents is unsaturated. As used herein, “adjacent” means that the two substituents involved can be on the same ring next to each other, or on two neighboring rings having the two closest available substitutable positions, such as 2, 2′ positions in a biphenyl, or 1, 8 position in a naphthalene, as long as they can form a stable fused ring system.

A compound of Formula (L_(A))_(n)-M-(L_(C))_(m), wherein the ligand L_(A) is of Formula I, and ligand L_(C) is selected from Formula I that is different than ligand L_(A), a monoanionic bidentate ligand, or a monoanionic monodentate ligand;

M is a metal; and n is 1 or 2, and m is 0, 1 or 2;

wherein Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B;

Z is selected from O or S;

Z¹ is selected from a carbene C or N; and Z² is selected from C or N;

R^(A) and R^(B) represent mono to the maximum allowable substitution, or no substitution;

each R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, or optionally, any two adjacent groups of R^(A) or R^(B) can join to form a carbocyclic ring or a heterocyclic ring, which is optionally substituted; or optionally R^(A) or R^(B) can join with the ligand L_(C) to form a multidentate ligand;

with the proviso that two adjacent ring carbons of Ring B form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons,

wherein X is selected from NR^(N), O, S, or Se; wherein R^(N) is selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl, and combinations thereof,

Y¹, Y², Y³, and Y⁴ are independently CR^(Y1), CR^(Y2), CR^(Y3), and CR^(Y4), respectively, or N, and Ring D has no more than two nitrogen ring atoms;

R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently selected from the group hydrogen, deuterium, fluorine, alkyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, acyl, ester, nitrile, isonitrile, sulfanyl, and combinations thereof, or any two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can join to form a fused 6-member ring, or a fused 5-member ring, each of which can be carbocyclic or heterocyclic, and aromatic or non-aromatic, each of which is optionally substituted.

In certain instances, embodiments of the compounds of Formula I can include those compounds with R^(A) and R^(B) independently hydrogen or a substituent selected from any one group list of preferred general substituents, or any one group list of more preferred substituents, defined above. For example, in select embodiments R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof. Moreover, a select list of the groups R^(A) and R^(B) can include: an alkyl with one to six carbons optionally substituted with one or more deuterium, nitrile, aryl, heteraryl, or amino; and aryl or heteraryl, each of which is optionally substituted with one or more deuterium, nitrile, aryl, or heteraryl.

Likewise, in certain instances, embodiments of the compounds of Formula I can include those compounds with R^(Y1), R^(Y2), R^(Y3), and R^(Y4) independently hydrogen or a substituent selected from any one group list of more preferred substituents defined above. For example, in select embodiments R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently hydrogen or a substituent selected from the group consisting of deuterium, alkyl, amino, silyl, aryl, heteroaryl, nitrile, and combinations thereof. Moreover, a select list of the groups R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can include: an alkyl with one to six carbons optionally substituted with one or more deuterium, nitrile, aryl, heteraryl, or amino; and aryl or heteraryl, each of which is optionally substituted with one or more deuterium, alkyl, nitrile, aryl, or heteraryl.

Compounds of Formula I of particular interest will have extended aromatic ring systems in which an aryl or heteroaryl ring is fused to the aromatic ring of formula D. Accordingly, these compounds of interest will necessarily include two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) that join to form a fused 6-member ring, or a fused 5-member ring, each of which is aromatic and can be carbocyclic or heterocyclic. Moreover, this additional fused 6-member ring or fused 5-member ring can include one to four additional fused aromatic rings. For example, see the extended ring systems represented by ring groups G1 to G14, infra.

In one embodiment, the compound of Formula I will include a ligand L_(A) represented by Formula II or Formula III,

wherein Ring A is 5-member or 6-member heteroaryl ring;

wherein for Formula II; X₁ is selected from CR^(1A) or N, X₂ is selected from CR^(2A), N or NR^(N), and X₃ is C or N; wherein if X₃ is N then X₂ is CR^(2A);

wherein for Formula III, X₂ is CR^(2A), N or NR^(N); and R^(1A) and R^(2A) are represented by R^(A);

each R^(B) is represented by R¹, R², R³, and R⁴; wherein

any two adjacent R¹, R², R³, and R⁴ can join to form a ring of formula D, with the proviso that at least one of the adjacent groups selected from R¹ and R², R² and R³, or R³ and R⁴, do join to form a group of formula D.

In one embodiment, the compounds of Formulae II or III the groups R¹ and R² join to form the group of formula D. In another embodiment, the groups R² and R³ join to form the group of formula D.

In one embodiment, the compounds of Formulae I, II, or III will include a metal M selected from the group consisting of Ag, Au, Be, a first row transition metal; and a Group IIIA to VA element selected from Al, Ga, In, Sn, Tl, Pb, or Bi. In select embodiments, the metal M is selected from Zn, Al, Be, or Sn.

In one embodiment, the compounds of Formulae I or II will include a Ring A selected from the group consisting of pyridyl, pyrazinyl, pyrimidyl, and imidazole. Select embodiments of compounds of Formula II will include X₁ as CR^(1A). Moreover, in certain instances, R^(1A) is selected from alkyl, aryl, or heteroaryl. In another embodiment, the compounds of Formula II, X₂ is CR^(2A), and R^(2A) and an adjacent R^(A) join together to form a fused aromatic ring.

In one embodiment, the compounds of Formulae I, II, or III will include the joining of one or two of the adjacent groups selected from R^(Y1) and R^(Y2), R^(Y2) and R^(Y3), or R^(Y3) and R^(Y4), to form a fused 6-member or 5-member aromatic ring, which is optionally substituted or fuses to another aromatic ring. As noted with Formula I above, the compounds of Formulae II or III of particular interest will have extended aromatic ring systems, i.e., one to four additional fused 6-member aromatic rings or fused 5-member aromatic rings rings. For example, see the extended ring systems represented by ring groups G1 to G14, infra.

In one embodiment, a compound of Formulae I, II, or III will include a ligand L_(A) that is linked with another ligand L_(A), which is the same or different, or a ligand L_(A) that is linked to a ligand L_(C), to form a tridentate or tetradentate ligand.

In one embodiment, the compounds of Formula I is a homoleptic compound of Formula IVA or Formula IVB

wherein Z, X, M, R^(A), R⁴, R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are defined above,

In one embodiment, the compounds of Formula I is a homoleptic compound of Formula VA or Formula VB

wherein Z, X, M, R^(A), R⁴, R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are defined above;

W¹, W², W³, and W⁴ are independently selected from CR^(W) or N, with no more than two of W¹, W², W³, and W⁴ being N, wherein the dotted lines from ring carbons of ring W represent the fusion of ring atoms to the adjacent ring, and

each R^(W) is independently selected from hydrogen, deuterium, fluorine, alkyl, cycloalkyl, silyl, aryl, heteroaryl, and combinations thereof, or optionally, two adjacent R^(W) join to form a fused aryl or heteroaryl ring.

Compounds of Formula II above that are of particular interest will have each of X₁, X₂ and X₃ being C, and Z is O to provide a compound of Formula IIA. Select compounds of Formula IIA are identified as Compound Nos. 1 to 428 in Table I.

TABLE I Formula IIA

Select Compounds of Formula IIA No. R^(A) R¹/R² R³ R⁴ n Me  1. H 1,2-G1 H H 2 Zn  2. H 2,1-G1 H H 2 Zn  3. H 1,2-G1 Ph H 2 Zn  4. H 2,1-G1 Ph H 2 Zn  5. H 1,2-G1 H Ph 2 Zn  6. H 2,1-G1 H Ph 2 Zn  7. 3-Ph 1,2-G1 H H 2 Zn  8. 3-Ph 2,1-G1 H H 2 Zn  9. 3-Ph 1,2-G1 Ph H 2 Zn  10. 3-Ph 2,1-G1 Ph H 2 Zn  11. 4-Ph 1,2-G1 H H 2 Zn  12. 4-Ph 2,1-G1 H H 2 Zn  13. 4-Ph 1,2-G1 Ph H 2 Zn  14. 4-Ph 2,1-G1 Ph H 2 Zn  15. H 1,2-G2 H H 2 Zn  16. H 2,1-G2 H H 2 Zn  17. H 1,2-G2 Ph H 2 Zn  18. H 2,1-G2 Ph H 2 Zn  19. H 1,2-G2 H Ph 2 Zn  20. H 2,1-G2 H Ph 2 Zn  21. 3-Ph 1,2-G2 H H 2 Zn  22. 3-Ph 2,1-G2 H H 2 Zn  23. 3-Ph 1,2-G2 Ph H 2 Zn  24. 3-Ph 2,1-G2 Ph H 2 Zn  25. 4-Ph 1,2-G2 H H 2 Zn  26. 4-Ph 2,1-G2 H H 2 Zn  27. 4-Ph 1,2-G2 Ph H 2 Zn  28. 4-Ph 2,1-G2 Ph H 2 Zn  29. H 1,2-G3 H H 2 Zn  30. H 2,1-G3 H H 2 Zn  31. H 1,2-G3 Ph H 2 Zn  32. H 2,1-G3 Ph H 2 Zn  33. H 1,2-G3 H Ph 2 Zn  34. H 2,1-G3 H Ph 2 Zn  35. 3-Ph 1,2-G3 H H 2 Zn  36. 3-Ph 2,1-G3 H H 2 Zn  37. 3-Ph 1,2-G3 Ph H 2 Zn  38. 3-Ph 2,1-G3 Ph H 2 Zn  39. 4-Ph 1,2-G3 H H 2 Zn  40. 4-Ph 2,1-G3 H H 2 Zn  41. 4-Ph 1,2-G3 Ph H 2 Zn  42. 4-Ph 2,1-G3 Ph H 2 Zn No. R^(A) R¹ R²/R³ R⁴ n M  43. H H 2,3-G1 H 2 Zn  44. H H 3,2-G1 H 2 Zn  45. 3-Ph H 2,3-G1 H 2 Zn  46. 3-Ph H 3,2-G1 H 2 Zn  47. 3-Ph H 2,3-G1 H 2 Zn  48. 4-Ph H 3,2-G1 H 2 Zn  49. H H 2,3-G2 H 2 Zn  50. H H 3,2-G2 H 2 Zn  51. 3-Ph H 2,3-G2 H 2 Zn  52. 3-Ph H 3,2-G2 H 2 Zn  53. 3-Ph H 2,3-G2 H 2 Zn  54. 4-Ph H 3,2-G2 H 2 Zn  55. H H 2,3-G3 H 2 Zn  56. H H 3,2-G3 H 2 Zn  57. 3-Ph H 2,3-G3 H 2 Zn  58. 3-Ph H 3,2-G3 H 2 Zn  59. 3-Ph H 2,3-G3 H 2 Zn  60. 4-Ph H 3,2-G3 H 2 Zn No. R^(A) R¹ R² R3/R⁴ n M  61. H H H 3,4-G1 2 Zn  62. H H H 4,3-G1 2 Zn  63. 3-Ph H H 3,4-G1 2 Zn  64. 3-Ph H H 4,3-G1 2 Zn  65. 3-Ph H H 3,4-G1 2 Zn  66. H H H 4,3-G1 2 Zn  67. H H H 3,4-G2 2 Zn  68. 3-Ph H H 4,3-G2 2 Zn  69. 3-Ph H H 3,4-G2 2 Zn  70. 3-Ph H H 4,3-G2 2 Zn  71. 4-Ph H H 3,4-G2 2 Zn  72. H H H 4,3-G2 2 Zn  73. H H H 3,4-G3 2 Zn  74. 3-Ph H H 4,3-G3 2 Zn  75. 3-Ph H H 3,4-G3 2 Zn  76. 3-Ph H H 4,3-G3 2 Zn  77. 4-Ph H H 3,4-G3 2 Zn  78. H H H 4,3-G3 2 Zn No. R^(A) R¹/R² R³ R⁴ n M  79. H 1,2-G1 H H 2 Be  80. H 2,1-G1 H H 2 Be  81. H 1,2-G1 Ph H 2 Be  82. H 2,1-G1 Ph H 2 Be  83. H 1,2-G1 H Ph 2 Be  84. H 2,1-G1 H Ph 2 Be  85. 3-Ph 1,2-G1 H H 2 Be  86. 3-Ph 2,1-G1 H H 2 Be  87. 3-Ph 1,2-G1 Ph H 2 Be  88. 3-Ph 2,1-G1 Ph H 2 Be  89. 4-Ph 1,2-G1 H H 2 Be  90. 4-Ph 2,1-G1 H H 2 Be  91. 4-Ph 1,2-G1 Ph H 2 Be  92. 4-Ph 2,1-G1 Ph H 2 Be  93. H 1,2-G2 H H 2 Be  94. H 2,1-G2 H H 2 Be  95. H 1,2-G2 Ph H 2 Be  96. H 2,1-G2 Ph H 2 Be  97. H 1,2-G2 H Ph 2 Be  98. H 2,1-G2 H Ph 2 Be  99. 3-Ph 1,2-G2 H H 2 Be 100. 3-Ph 2,1-G2 H H 2 Be 101. 3-Ph 1,2-G2 Ph H 2 Be 102. 3-Ph 2,1-G2 Ph H 2 Be 103. 4-Ph 1,2-G2 H H 2 Be 104. 4-Ph 2,1-G2 H H 2 Be 105. 4-Ph 1,2-G2 Ph H 2 Be 106. 4-Ph 2,1-G2 Ph H 2 Be 107. H 1,2-G2 H H 2 Be 108. H 2,1-G3 H H 2 Be 109. H 1,2-G3 Ph H 2 Be 110. H 2,1-G3 Ph H 2 Be 111. H 1,2-G3 H Ph 2 Be 112. H 2,1-G3 H Ph 2 Be 113. 3-Ph 1,2-G3 H H 2 Be 114. 3-Ph 2,1-G3 H H 2 Be 115. 3-Ph 1,2-G3 Ph H 2 Be 116. 3-Ph 2,1-G3 Ph H 2 Be 117. 4-Ph 1,2-G3 H H 2 Be 118. 4-Ph 2,1-G3 H H 2 Be 119. 4-Ph 1,2-G3 Ph H 2 Be 120. 4-Ph 2,1-G3 Ph H 2 Be No. R^(A) R¹ R²/R³ R⁴ n M 121. H H 2,3-G1 H 2 Be 122. H H 3,2-G1 H 2 Be 123. 3-Ph H 2,3-G1 H 2 Be 124. 3-Ph H 3,2-G1 H 2 Be 125. 3-Ph H 2,3-G1 H 2 Be 126. 4-Ph H 3,2-G1 H 2 Be 127. H H 2,3-G2 H 2 Be 128. H H 3,2-G2 H 2 Be 129. 3-Ph H 2,3-G2 H 2 Be 130. 3-Ph H 3,2-G2 H 2 Be 131. 3-Ph H 2,3-G2 H 2 Be 132. 4-Ph H 3,2-G2 H 2 Be 133. H H 2,3-G3 H 2 Be 134. H H 3,2-G3 H 2 Be 135. 3-Ph H 2,3-G3 H 2 Be 136. 3-Ph H 3,2-G3 H 2 Be 137. 3-Ph H 2,3-G3 H 2 Be 138. 4-Ph H 3,2-G3 H 2 Be No. R^(A) R¹ R² R³/R⁴ n M 139. H H H 3,4-G1 2 Be 140. H H H 4,3-G1 2 Be 141. 3-Ph H H 3,4-G1 2 Be 142. 3-Ph H H 4,3-G1 2 Be 143. 3-Ph H H 3,4-G1 2 Be 144. H H H 4,3-G1 2 Be 145. H H H 3,4-G2 2 Be 146. 3-Ph H H 4,3-G2 2 Be 147. 3-Ph H H 3,4-G2 2 Be 148. 3-Ph H H 4,3-G2 2 Be 149. 4-Ph H H 3,4-G2 2 Be 150. H H H 4,3-G2 2 Be 151. H H H 3,4-G3 2 Be 152. 3-Ph H H 4,3-G3 2 Be 153. 3-Ph H H 3,4-G3 2 Be 154. 3-Ph H H 4,3-G3 2 Be 155. 4-Ph H H 3,4-G3 2 Be 156. H H H 4,3-G3 2 Be No. R^(A) R¹/R² R³ R⁴ n M 157. H 1,2-G1 H H 3 Al 158. H 2,1-G1 H H 3 Al 159. H 1,2-G1 Ph H 3 Al 160. H 2,1-G1 Ph H 3 Al 161. H 1,2-G1 H Ph 3 Al 162. H 2,1-G1 H Ph 3 Al 163. 3-Ph 1,2-G1 H H 3 Al 164. 3-Ph 2,1-G1 H H 3 Al 165. 3-Ph 1,2-G1 Ph H 3 Al 166. 3-Ph 2,1-G1 Ph H 3 Al 167. 4-Ph 1,2-G1 H H 3 Al 168. 4-Ph 2,1-G1 H H 3 Al 169. 4-Ph 1,2-G1 Ph H 3 Al 170. 4-Ph 2,1-G1 Ph H 3 Al 171. H 1,2-G2 H H 3 Al 172. H 2,1-G2 H H 3 Al 173. H 1,2-G2 Ph H 3 Al 174. H 2,1-G2 Ph H 3 Al 175. H 1,2-G2 H Ph 3 Al 176. H 2,1-G2 H Ph 3 Al 177. 3-Ph 1,2-G2 H H 3 Al 178. 3-Ph 2,1-G2 H H 3 Al 179. 3-Ph 1,2-G2 Ph H 3 Al 180. 3-Ph 2,1-G2 Ph H 3 Al 181. 4-Ph 1,2-G2 H H 3 Al 182. 4-Ph 2,1-G2 H H 3 Al 183. 4-Ph 1,2-G2 Ph H 3 Al 184. 4-Ph 2,1-G2 Ph H 3 Al 185. H 1,2-G3 H H 3 Al 186. H 2,1-G3 H H 3 Al 187. H 1,2-G3 Ph H 3 Al 188. H 2,1-G3 Ph H 3 Al 189. H 1,2-G3 H Ph 3 Al 190. H 2,1-G3 H Ph 3 Al 191. 3-Ph 1,2-G3 H H 3 Al 192. 3-Ph 2,1-G3 H H 3 Al 193. 3-Ph 1,2-G3 Ph H 3 Al 194. 3-Ph 2,1-G3 Ph H 3 Al 195. 4-Ph 1,2-G3 H H 3 Al 196. 4-Ph 2,1-G3 H H 3 Al 197. 4-Ph 1,2-G3 Ph H 3 Al 198. 4-Ph 2,1-G3 Ph H 3 Al No. R^(A) R¹ R²/R³ R⁴ n M 199. H H 2,3-G1 H 3 Al 200. H H 3,2-G1 H 3 Al 201. 3-Ph H 2,3-G1 H 3 Al 202. 3-Ph H 3,2-G1 H 3 Al 203. 3-Ph H 2,3-G1 H 3 Al 204. 4-Ph H 3,2-G1 H 3 Al 205. H H 2,3-G2 H 3 Al 206. H H 3,2-G2 H 3 Al 207. 3-Ph H 2,3-G2 H 3 Al 208. 3-Ph H 3,2-G2 H 3 Al 209. 3-Ph H 2,3-G2 H 3 Al 210. 4-Ph H 3,2-G2 H 3 Al 211. H H 2,3-G3 H 3 Al 212. H H 3,2-G3 H 3 Al 213. 3-Ph H 2,3-G3 H 3 Al 214. 3-Ph H 3,2-G3 H 3 Al 215. 3-Ph H 2,3-G3 H 3 Al 216. 4-Ph H 3,2-G3 H 3 Al No. R^(A) R¹ R² R³/R⁴ n M 217. H H H 3,4-G1 3 Al 218. H H H 4,3-G1 3 Al 219. 3-Ph H H 3,4-G1 3 Al 220 3-Ph H H 4,3-G1 3 Al 221. 3-Ph H H 3,4-G1 3 Al 222. H H H 4,3-G1 3 Al 223. H H H 3,4-G2 3 Al 224. 3-Ph H H 4,3-G2 3 Al 225. 3-Ph H H 3,4-G2 3 Al 226. 3-Ph H H 4,3-G2 3 Al 227. 4-Ph H H 3,4-G2 3 Al 228. H H H 4,3-G2 3 Al 229. H H H 3,4-G3 3 Al 230. 3-Ph H H 4,3-G3 3 Al 231. 3-Ph H H 3,4-G3 3 Al 232. 3-Ph H H 4,3-G3 3 Al 233. 4-Ph H H 3,4-G3 3 Al 234. H H H 4,3-G3 3 Al No. R^(A) R¹/R² R³ R⁴ n M 235. H 1,2-G1 H H 3 Bi 236. H 2,1-G1 H H 3 Bi 237. H 1,2-G1 Ph H 3 Bi 238. H 2,1-G1 Ph H 3 Bi 239. H 1,2-G1 H Ph 3 Bi 240. H 2,1-G1 H Ph 3 Bi 241. 3-Ph 1,2-G1 H H 3 Bi 242. 3-Ph 2,1-G1 H H 3 Bi 243. 3-Ph 1,2-G1 Ph H 3 Bi 244. 3-Ph 2,1-G1 Ph H 3 Bi 245. 4-Ph 1,2-G1 H H 3 Bi 246. 4-Ph 2,1-G1 H H 3 Bi 247. 4-Ph 1,2-G1 Ph H 3 Bi 248. 4-Ph 2,1-G1 Ph H 3 Bi 249. H 1,2-G2 H H 3 Bi 250. H 2,1-G2 H H 3 Bi 251. H 1,2-G2 Ph H 3 Bi 252. H 2,1-G2 Ph H 3 Bi 253. H 1,2-G2 H Ph 3 Bi 254. H 2,1-G2 H Ph 3 Bi 255. 3-Ph 1,2-G2 H H 3 Bi 256. 3-Ph 2,1-G2 H H 3 Bi 257. 3-Ph 1,2-G2 Ph H 3 Bi 258. 3-Ph 2,1-G2 Ph H 3 Bi 259. 4-Ph 1,2-G2 H H 3 Bi 260. 4-Ph 2,1-G2 H H 3 Bi 261. 4-Ph 1,2-G2 Ph H 3 Bi 262. 4-Ph 2,1-G2 Ph H 3 Bi 263. H 1,2-G3 H H 3 Bi 264. H 2,1-G3 H H 3 Bi 265. H 1,2-G3 Ph H 3 Bi 266. H 2,1-G3 Ph H 3 Bi 267. H 1,2-G3 H Ph 3 Bi 268. H 2,1-G3 H Ph 3 Bi 269. 3-Ph 1,2-G3 H H 3 Bi 270. 3-Ph 2,1-G3 H H 3 Bi 271. 3-Ph 1,2-G3 Ph H 3 Bi 272. 3-Ph 2,1-G3 Ph H 3 Bi 273. 4-Ph 1,2-G3 H H 3 Bi 274. 4-Ph 2,1-G3 H H 3 Bi 275. 4-Ph 1,2-G3 Ph H 3 Bi 276. 4-Ph 2,1-G3 Ph H 3 Bi No. R^(A) R¹ R²/R³ R⁴ n M 277. H H 2,3-G1 H 3 Bi 278. H H 3,2-G1 H 3 Bi 279. 3-Ph H 2,3-G1 H 3 Bi 280. 3-Ph H 3,2-G1 H 3 Bi 281. 3-Ph H 2,3-G1 H 3 Bi 282. 4-Ph H 3,2-G1 H 3 Bi 283. H H 2,3-G2 H 3 Bi 284. H H 3,2-G2 H 3 Bi 285. 3-Ph H 2,3-G2 H 3 Bi 286. 3-Ph H 3,2-G2 H 3 Bi 287. 3-Ph H 2,3-G2 H 3 Bi 288. 4-Ph H 3,2-G2 H 3 Bi 289. H H 2,3-G3 H 3 Bi 290. H H 3,2-G3 H 3 Bi 291. 3-Ph H 2,3-G3 H 3 Bi 292. 3-Ph H 3,2-G3 H 3 Bi 293. 3-Ph H 2,3-G3 H 3 Bi 294. 4-Ph H 3,2-G3 H 3 Bi No. R^(A) R¹ R² R³/R⁴ n M 295. H H H 3,4-G1 3 Bi 296. H H H 4,3-G1 3 Bi 297. 3-Ph H H 3,4-G1 3 Bi 298. 3-Ph H H 4,3-G1 3 Bi 299. 3-Ph H H 3,4-G1 3 Bi 300. H H H 4,3-G1 3 Bi 301. H H H 3,4-G2 3 Bi 302. 3-Ph H H 4,3-G2 3 Bi 303. 3-Ph H H 3,4-G2 3 Bi 304. 3-Ph H H 4,3-G2 3 Bi 305. 4-Ph H H 3,4-G2 3 Bi 306. H H H 4,3-G2 3 Bi 307. H H H 3,4-G3 3 Bi 308. 3-Ph H H 4,3-G3 3 Bi 309. 3-Ph H H 3,4-G3 3 Bi 310. 3-Ph H H 4,3-G3 3 Bi 311. 4-Ph H H 3,4-G3 3 Bi 312. H H H 4,3-G3 3 Bi No. R^(A) R^(1/)R² R³ R⁴ n M 313. H 1,2-G4 H H 2 Zn 314. 3-Ph 1,2-G4 H H 2 Zn 315. 4-Ph 1.2-G4 H H 2 Zn 316. H 2,1-G4 H H 2 Zn 317. 3-Ph 2,1-G4 H H 2 Zn 318. 4-Ph 2,1-G4 H H 2 Zn 319. H 1,2-G5 H H 2 Zn 320. 3-Ph 1,2-G5 H H 2 Zn 321. 4-Ph 1,2-G5 H H 2 Zn 322. H 2,1-G5 H H 2 Zn 323. 3-Ph 2,1-G5 H H 2 Zn 324. 4-Ph 2,1-G5 H H 2 Zn 325. H 1,2-G6 H H 2 Zn 326. 3-Ph 1,2-G6 H H 2 Zn 327. 4-Ph 1,2-G6 H H 2 Zn 328. H 2,1-G6 H H 2 Zn 329. 3-Ph 2,1-G6 H H 2 Zn 330. 4-Ph 2,1-G6 H H 2 Zn 331. H 1,2-G7 H H 2 Zn 332. 3-Ph 1,2-G7 H H 2 Zn 333. 4-Ph 1,2-G7 H H 2 Zn 334. H 2,1-G7 H H 2 Zn 335. 3-Ph 2,1-G7 H H 2 Zn 336. 4-Ph 2,1-G7 H H 2 Zn 337. H 1,2-G8 H H 2 Zn 338. 3-Ph 1,2-G8 H H 2 Zn 339. 4-Ph 1,2-G8 H H 2 Zn 340. H 2,1-G8 H H 2 Zn 341. 3-Ph 2,1-G8 H H 2 Zn 342. 4-Ph 2,1-G8 H H 2 Zn 343. H 1,2-G9 H H 2 Zn 344. 3-Ph 1,2-G9 H H 2 Zn 345. 4-Ph 1,2-G9 H H 2 Zn 346. H 2,1-G9 H H 2 Zn 347. 3-Ph 2,1-G9 H H 2 Zn 348. 4-Ph 2,1-G9 H H 2 Zn 349. H 1,2-G10 H H 2 Zn 350. 3-Ph 1,2-G10 H H 2 Zn 351. 4-Ph 1,2-G10 H H 2 Zn 352. H 2,1-G10 H H 2 Zn 353. 3-Ph 2,1-G10 H H 2 Zn 354. 4-Ph 2,1-G10 H H 2 Zn 355. H 1,2-G11 H H 2 Zn 356. 3-Ph 1,2-G11 H H 2 Zn 357. 4-Ph 1,2-G11 H H 2 Zn 358. H 2,1-G11 H H 2 Zn 359. 3-Ph 2,1-G11 H H 2 Zn 360. 4-Ph 2,1-G11 H H 2 Zn 361. H 1,2-G12 H H 2 Zn 362. 3-Ph 1,2-G12 H H 2 Zn 363. 4-Ph 1,2-G12 H H 2 Zn 364. H 2,1-G12 H H 2 Zn 365. 3-Ph 2,1-G12 H H 2 Zn 366. 4-Ph 2,1-G12 H H 2 Zn 367. H 1,2-G13 H H 2 Zn 368. H 1,2-G14 H H 2 Zn 369. H 2,1-G13 H H 2 Zn 370. H 2,1-G14 H H 2 Zn No. R^(A) R¹ R²/R³ R⁴ n M 371. H H 2,3-G4 H 2 Zn 372. 3-Ph H 2,3-G4 H 2 Zn 373. 4-Ph H 2,3-G4 H 2 Zn 374. H H 3,2-G4 H 2 Zn 375. 3-Ph H 3,2-G4 H 2 Zn 376. 4-Ph H 3,2-G4 H 2 Zn 377. H H 2,3-G5 H 2 Zn 378. 3-Ph H 2,3-G5 H 2 Zn 379. 4-Ph H 2,3-G5 H 2 Zn 380. H H 3,2-G5 H 2 Zn 381. 3-Ph H 3,2-G5 H 2 Zn 382. 4-Ph H 3,2-G5 H 2 Zn 383. H H 2,3-G6 H 2 Zn 384. 3-Ph H 2,3-G6 H 2 Zn 385. 4-Ph H 2,3-G6 H 2 Zn 386. H H 3,2-G6 H 2 Zn 387. 3-Ph H 3,2-G6 H 2 Zn 388. 4-Ph H 3,2-G6 H 2 Zn 389. H H 2,3-G7 H 2 Zn 390. 3-Ph H 2,3-G7 H 2 Zn 391. 4-Ph H 2,3-G7 H 2 Zn 392. H H 3,2-G7 H 2 Zn 393. 3-Ph H 3,2-G7 H 2 Zn 394. 4-Ph H 3,2-G7 H 2 Zn 395. H H 2,3-G8 H 2 Zn 396. 3-Ph H 2,3-G8 H 2 Zn 397. 4-Ph H 2,3-G8 H 2 Zn 398. H H 3,2-G8 H 2 Zn 399. 3-Ph H 3,2-G8 H 2 Zn 400 4-Ph H 3,2-G8 H 2 Zn 401. H H 2,3-G9 H 2 Zn 402. 3-Ph H 2,3-G9 H 2 Zn 403. 4-Ph H 2,3-G9 H 2 Zn 404. H H 3,2-G9 H 2 Zn 405. 3-Ph H 3,2-G9 H 2 Zn 406. 4-Ph H 3,2-G9 H 2 Zn 407. H H 2,3-G10 H 2 Zn 408. 3-Ph H 2,3-G10 H 2 Zn 409. 4-Ph H 2,3-G10 H 2 Zn 410 H H 3,2-G10 H 2 Zn 411. 3-Ph H 3,2-G10 H 2 Zn 412. 4-Ph H 3,2-G10 H 2 Zn 413. H H 2,3-G11 H 2 Zn 414. 3-Ph H 2,3-G11 H 2 Zn 415. 4-Ph H 2,3-G11 H 2 Zn 416. H H 3,2-G11 H 2 Zn 417. 3-Ph H 3,2-G11 H 2 Zn 418. 4-Ph H 3,2-G11 H 2 Zn 419. H H 2,3-G12 H 2 Zn 420. 3-Ph H 2,3-G12 H 2 Zn 421. 4-Ph H 2,3-G12 H 2 Zn 422. H H 3,2-G12 H 2 Zn 423. 3-Ph H 3,2-G12 H 2 Zn 424. 4-Ph H 3,2-G12 H 2 Zn 425. H H 2,3-G13 H 2 Zn 426. H H 2,3-G14 H 2 Zn 427. H H 3,2-G13 H 2 Zn 428. H H 3,2-G14 H 2 Zn

wherein the ring group of G1 to G14 are defined as follows:

A person of ordinary skill understands that the column of Table I labeled as R^(A) represents each of R^(A) groups as hydrogen unless another specific group as a specified ring position is listed. For example, Compounds 1 to 6 lists R^(A) as H, and this represents that each ring carbon of the coordinating pyridine is CH. On the other hand, Compounds 7 to 10 lists R^(A) as 3-Ph, and this represents that each ring carbon of the coordinating pyridine is CH with the exception of the 3-carbon which is CPh. Likewise, Compounds 11 to 14 lists R^(A) as 4-Ph, and this represents that each ring carbon of the coordinating pyridine is CH with the exception of the 4-carbon which is CPh.

Compounds of Formula I that include one or two ligands L_(C) are also of interest. Accordingly, we describe compounds of Formula I wherein m is 1 or 2, and the ligand L_(c) is independently selected from the group consisting of;

wherein R^(A), R^(B), and R^(C) represent from mono substitution to the possible maximum number of substitution, or no substitution; and

R_(a), R_(b), and R_(c) are are independently hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, nitrile, isonitrile, phosphino, sulfanyl, and any combination of substituents thereof, or any two adjacent R_(a), R_(b), and R_(c) can join to form an aliphatic, aryl or heteroaryl ring, which is optionally substituted.

We also describe an organic light emitting device (OLED) comprising:

an anode; a cathode; and an organic layer disposed between the anode and the cathode, the organic layer including a compound of Formula (L_(A))_(n)-M-(L_(C))_(m); wherein the ligand L_(A) is of Formula I, and ligand L_(C) is selected from Formula I that is different than ligand L_(A), a monoanionic bidentate ligand, or monodentate ligand, M is a metal, and n is 1 or 2, and m is 0, 1 or 2;

wherein Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B;

Z is selected from O or S;

Z¹ is selected from a carbene C or N; and Z² is selected from C or N;

R^(A) and R^(B) represent mono to the maximum allowable substitution, or no substitution;

each R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, or optionally, any two adjacent groups of R^(A) or R^(B) can join to form a carbocyclic ring or a heterocyclic ring, which is optionally substituted; or optionally R^(A) or R^(B) can join with the ligand L_(C) to form a multidentate ligand;

with the proviso that two adjacent ring carbons of Ring B form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons,

wherein X is selected from NR^(N), O, S, or Se;

Y¹, Y², Y³, and Y⁴ are independently CR^(Y1), CR^(Y2), CR^(Y3), and CR^(Y4), respectively, or N, and Ring D has no more than two nitrogen ring atoms;

R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently selected from the group hydrogen, deuterium, fluorine, alkyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, acyl, ester, nitrile, isonitrile, sulfanyl, and combinations thereof; or any two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can join to form a fused 6-member ring, or a fused 5-member ring, each of which can be carbocyclic or heterocyclic, and aromatic or non-aromatic, each of which is optionally substituted.

As part of the OLED, the compounds of Formulae I, II, IIA, III, IVA, IVB, VA, or VB are present as a co-host material in an organic layer present between an anode and a cathode. In one embodiment, a compound of Formulae I, II, IIA, III, IVA, IVB, VA, or VB is combined with a phosphorescent emitter dopant, a fluorescent emitter dopant, or a thermally activated delayed fluorescence emitter dopant, i.e., TADF (also referred to as E-type delayed fluorescence; see, e.g., U.S. application Ser. No. 15/700,352, which is hereby incorporated by reference in its entirety). In some instances, the organic layer can be what is referred to as a hybrid emitting layer and include a host material, a co-host material of a compound of Formulae I, II, IIA, III, IVA, IVB, VA, or VB, a phosphorescent emitter dopant, and a fluorescent dopant.

In one embodiment, a compound of Formulae I, II, IIA, III, IVA, IVB, VA, or VB is present as a co-host material in an organic layer and combined with a phosphorescent emitter having a peak emissive wavelength in a range from 440 nm to 510 nm, from 510 nm to 570 nm, or from 570 nm to 800 nm. In some instances, the compounds of Formulae I and II will have a Ring A selected from pyridyl, pyrazinyl, pyrimidyl, or imidazole. Moreover, in select instances, Ring A is selected from pyridyl, pyrazinyl, pyrimidyl, or imidazole, and the ring of formula D is attached at adjacent groups R¹ and R², or at adjacent groups R² and R³ as represented in Formula II.

It is our understanding that at least two prerequisites for molecular (compound) design should be considered: (1) only host with high-enough T1 can be considered; and (2) minimum carrier gap will be highly desirable to achieve good carrier injection and transportation. For each of the compounds of Formula I in Table II, the T1 energy is between 525 nm to 574 nm; which is high enough to support red phosphorescent OLEDS. Furthermore; each of the tested compounds has a carrier gap between 3.46 eV to 3.56 eV; which is much smaller than the carrier gap of comparative example 1 of 3.79 eV. Minimum carrier gap is highly desirable to achieve good carrier injection and transportation.

In accordance with this understanding, the compounds of Formula I of particular interest will include a T1 value in a range from 500 nm to 600 nm, from 520 nm to 590 nm, or from 520 nm to 570 nm. Moreover, it is also of interest to have these same compounds with the desired T1 values to have a carrier gap in a range from 3.2 eV to 3.75 eV, from 3.3 eV to 3.65 eV, or from 3.4 eV to 3.65 eV.

In some embodiments, the OLED has one or more characteristics selected from the group consisting of being flexible, being rollable, being foldable, being stretchable, and being curved. In some embodiments, the OLED is transparent or semi-transparent. In some embodiments, the OLED further comprises a layer comprising carbon nanotubes.

In some embodiments, the OLED further comprises a layer comprising a delayed fluorescent emitter. In some embodiments, the OLED comprises a RGB pixel arrangement or white plus color filter pixel arrangement. In some embodiments, the OLED is a mobile device, a hand held device, or a wearable device. In some embodiments, the OLED is a display panel having less than 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a display panel having at least 10 inch diagonal or 50 square inch area. In some embodiments, the OLED is a lighting panel.

According to another aspect, a formulation comprising the compound described herein is also disclosed.

The OLED disclosed herein can be incorporated into one or more of a consumer product, an electronic component module, and a lighting panel.

In yet another aspect of the present disclosure, a formulation that comprises the novel compound disclosed herein is described. The formulation can include one or more components selected from the group consisting of a solvent, a host, a hole injection material, hole transport material, electron blocking material, hole blocking material, and an electron transport layer material, disclosed herein.

The present disclosure encompasses any chemical structure comprising the novel compound of the present disclosure. In other words, the inventive compound can be a part of a larger chemical structure. Such chemical structure can be selected from the group consisting of a monomer, a polymer, a macromolecule, and a supramolecule (also known as supermolecule).

Combination with Other Materials

The materials described herein as useful for a particular layer in an organic light emitting device may be used in combination with a wide variety of other materials present in the device. For example, emissive dopants disclosed herein may be used in conjunction with a wide variety of hosts, transport layers, blocking layers, injection layers, electrodes and other layers that may be present. The materials described or referred to below are non-limiting examples of materials that may be useful in combination with the compounds disclosed herein, and one of skill in the art can readily consult the literature to identify other materials that may be useful in combination.

Conductivity Dopants:

A charge transport layer can be doped with conductivity dopants to substantially alter its density of charge carriers, which will in turn alter its conductivity. The conductivity is increased by generating charge carriers in the matrix material, and depending on the type of dopant, a change in the Fermi level of the semiconductor may also be achieved. Hole-transporting layer can be doped by p-type conductivity dopants and n-type conductivity dopants are used in the electron-transporting layer.

Non-limiting examples of the conductivity dopants that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: EP01617493, EP01968131, EP2020694, EP2684932, US20050139810, US20070160905, US20090167167, US2010288362, WO06081780, WO2009003455, WO2009008277, WO2009011327, WO2014009310, US2007252140, US2015060804, US20150123047, and US2012146012.

HIL/HTL:

A hole injecting/transporting material to be used in the present invention is not particularly limited, and any compound may be used as long as the compound is typically used as a hole injecting/transporting material. Examples of the material include, but are not limited to: a phthalocyanine or porphyrin derivative; an aromatic amine derivative; an indolocarbazole derivative; a polymer containing fluorohydrocarbon; a polymer with conductivity dopants; a conducting polymer, such as PEDOT/PSS; a self-assembly monomer derived from compounds such as phosphonic acid and silane derivatives; a metal oxide derivative, such as MoO_(x); a p-type semiconducting organic compound, such as 1,4,5,8,9,12-Hexaazatriphenylenehexacarbonitrile; a metal complex, and a cross-linkable compounds.

Examples of aromatic amine derivatives used in HIL or HTL include, but are not limited to the following general structures:

Each of Ar¹ to Ar⁹ is selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, and azulene; the group consisting of aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and the group consisting of 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Each Ar may be unsubstituted or may be substituted by a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, Ar¹ to Ar⁹ is independently selected from the group consisting of:

wherein k is an integer from 1 to 20; X¹⁰¹ to X¹⁰⁸ is C (including CH) or N; Z¹⁰¹ is NAr¹, O, or S; Ar¹ has the same group defined above.

Examples of metal complexes used in HIL or HTL include, but are not limited to the following general formula:

wherein Met is a metal, which can have an atomic weight greater than 40; (Y¹⁰¹-Y¹⁰²) is a bidentate ligand, Y¹⁰¹ and Y¹⁰² are independently selected from C, N, O, P, and S; L¹⁰¹ is an ancillary ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, (Y¹⁰¹-Y¹⁰²) is a 2-phenylpyridine derivative. In another aspect, (Y¹⁰¹-Y¹⁰²) is a carbene ligand. In another aspect, Met is selected from Ir, Pt, Os, and Zn. In a further aspect, the metal complex has a smallest oxidation potential in solution vs. Fc⁺/Fc couple less than about 0.6 V.

Non-limiting examples of the HIL and HTL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN102702075, DE102012005215, EP01624500, EP01698613, EP01806334, EP01930964, EP01972613, EP01997799, EP02011790, EP02055700, EP02055701, EP1725079, EP2085382, EP2660300, EP650955, JP07-073529, JP2005112765, JP2007091719, JP2008021687, JP2014-009196, KR20110088898, KR20130077473, TW201139402, U.S. Ser. No. 06/517,957, US20020158242, US20030162053, US20050123751, US20060182993, US20060240279, US20070145888, US20070181874, US20070278938, US20080014464, US20080091025, US20080106190, US20080124572, US20080145707, US20080220265, US20080233434, US20080303417, US2008107919, US20090115320, US20090167161, US2009066235, US2011007385, US20110163302, US2011240968, US2011278551, US2012205642, US2013241401, US20140117329, US2014183517, U.S. Pat. Nos. 5,061,569, 5,639,914, WO05075451, WO07125714, WO08023550, WO08023759, WO2009145016, WO2010061824, WO2011075644, WO2012177006, WO2013018530, WO2013039073, WO2013087142, WO2013118812, WO2013120577, WO2013157367, WO2013175747, WO2014002873, WO2014015935, WO2014015937, WO2014030872, WO2014030921, WO2014034791, WO2014104514, WO2014157018,

An electron blocking layer (EBL) may be used to reduce the number of electrons and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies, and/or longer lifetime, as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than the emitter closest to the EBL interface. In some embodiments, the EBL material has a higher LUMO (closer to the vacuum level) and/or higher triplet energy than one or more of the hosts closest to the EBL interface. In one aspect, the compound used in EBL contains the same molecule or the same functional groups used as one of the hosts described below.

Additional Hosts:

The light emitting layer of the organic EL device of the present invention preferably contains at least a metal complex as light emitting dopant material, and may contain one or more additional host materials using the metal complex as a dopant material. Examples of the host material are not particularly limited, and any metal complexes or organic compounds may be used as long as the triplet energy of the host is larger than that of the dopant. Any host material may be used with any dopant so long as the triplet criteria is satisfied.

Examples of metal complexes used as host are preferred to have the following general formula:

wherein Met is a metal; (Y¹⁰³-Y¹⁰⁴) is a bidentate ligand, Y¹⁰³ and Y¹⁰⁴ are independently selected from C, N, O, P, and S; L¹⁰¹ is an another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal; and k′+k″ is the maximum number of ligands that may be attached to the metal.

In one aspect, the metal complexes are:

wherein (O—N) is a bidentate ligand, having metal coordinated to atoms O and N.

In another aspect, Met is selected from Ir and Pt. In a further aspect, (Y¹⁰³-Y¹⁰⁴) is a carbene ligand.

In one aspect, the host compound contains at least one of the following groups selected from the group consisting of aromatic hydrocarbon cyclic compounds such as benzene, biphenyl, triphenyl, triphenylene, naphthalene, anthracene, phenalene, phenanthrene, fluorene, pyrene, chrysene, perylene, azulene; group consisting aromatic heterocyclic compounds such as dibenzothiophene, dibenzofuran, dibenzoselenophene, furan, thiophene, benzofuran, benzothiophene, benzoselenophene, carbazole, indolocarbazole, pyridylindole, pyrrolodipyridine, pyrazole, imidazole, triazole, oxazole, thiazole, oxadiazole, oxatriazole, dioxazole, thiadiazole, pyridine, pyridazine, pyrimidine, pyrazine, triazine, oxazine, oxathiazine, oxadiazine, indole, benzimidazole, indazole, indoxazine, benzoxazole, benzisoxazole, benzothiazole, quinoline, isoquinoline, cinnoline, quinazoline, quinoxaline, naphthyridine, phthalazine, pteridine, xanthene, acridine, phenazine, phenothiazine, phenoxazine, benzofuropyridine, furodipyridine, benzothienopyridine, thienodipyridine, benzoselenophenopyridine, and selenophenodipyridine; and group consisting 2 to 10 cyclic structural units which are groups of the same type or different types selected from the aromatic hydrocarbon cyclic group and the aromatic heterocyclic group and are bonded to each other directly or via at least one of oxygen atom, nitrogen atom, sulfur atom, silicon atom, phosphorus atom, boron atom, chain structural unit and the aliphatic cyclic group. Wherein each group is further substituted by a substituent selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof.

In one aspect, host compound contains at least one of the following groups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxlic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonylo, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. k is an integer from 0 to 20 or 1 to 20. X¹⁰¹ to X¹⁰⁸ are independently selected from C (including CH) or N. Z¹⁰¹ and Z¹⁰² are independently selected from NR¹⁰¹, O, or S.

Non-limiting examples of the additional host materials that may be used in an OLED in combination with the host compound disclosed herein are exemplified below together with references that disclose those materials: EP2034538, EP2034538A, EP2757608, JP2007254297, KR20100079458, KR20120088644, KR20120129733, KR20130115564, TW201329200, US20030175553, US20050238919, US20060280965, US20090017330, US20090030202, US20090167162, US20090302743, US20090309488, US20100012931, US20100084966, US20100187984, US2010187984, US2012075273, US2012126221, US2013009543, US2013105787, US2013175519, US2014001446, US20140183503, US20140225088, US2014034914, U.S. Pat. No. 7,154,114, WO2001039234, WO2004093207, WO2005014551, WO2005089025, WO2006072002, WO2006114966, WO2007063754, WO2008056746, WO2009003898, WO2009021126, WO2009063833, WO2009066778, WO2009066779, WO2009086028, WO2010056066, WO2010107244, WO2011081423, WO2011081431, WO2011086863, WO2012128298, WO2012133644, WO2012133649, WO2013024872, WO2013035275, WO2013081315, WO2013191404, WO2014142472, US20170263869, US20160163995, U.S. Pat. No. 9,466,803.

Emitter:

An emitter example is not particularly limited, and any compound may be used as long as the compound is typically used as an emitter material. Examples of suitable emitter materials include, but are not limited to, compounds which can produce emissions via phosphorescence, fluorescence, thermally activated delayed fluorescence, i.e., TADF (also referred to as E-type delayed fluorescence; see, e.g., U.S. application Ser. No. 15/700,352, which is hereby incorporated by reference in its entirety), triplet-triplet annihilation, or combinations of these processes. In some embodiments, the emissive dopant can be a racemic mixture, or can be enriched in one enantiomer.

Non-limiting examples of the emitter materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103694277, CN1696137, EB01238981, EP01239526, EP01961743, EP1239526, EP1244155, EP1642951, EP1647554, EP1841834, EP1841834B, EP2062907, EP2730583, JP2012074444, JP2013110263, JP4478555, KR1020090133652, KR20120032054, KR20130043460, TW201332980, U.S. Ser. No. 06/699,599, U.S. Ser. No. 06/916,554, US20010019782, US20020034656, US20030068526, US20030072964, US20030138657, US20050123788, US20050244673, US2005123791, US2005260449, US20060008670, US20060065890, US20060127696, US20060134459, US20060134462, US20060202194, US20060251923, US20070034863, US20070087321, US20070103060, US20070111026, US20070190359, US20070231600, US2007034863, US2007104979, US2007104980, US2007138437, US2007224450, US2007278936, US20080020237, US20080233410, US20080261076, US20080297033, US200805851, US2008161567, US2008210930, US20090039776, US20090108737, US20090115322, US20090179555, US2009085476, US2009104472, US20100090591, US20100148663, US20100244004, US20100295032, US2010102716, US2010105902, US2010244004, US2010270916, US20110057559, US20110108822, US20110204333, US2011215710, US2011227049, US2011285275, US2012292601, US20130146848, US2013033172, US2013165653, US2013181190, US2013334521, US20140246656, US2014103305, U.S. Pat. Nos. 6,303,238, 6,413,656, 6,653,654, 6,670,645, 6,687,266, 6,835,469, 6,921,915, 7,279,704, 7,332,232, 7,378,162, 7,534,505, 7,675,228, 7,728,137, 7,740,957, 7,759,489, 7,951,947, 8,067,099, 8,592,586, 8,871,361, WO06081973, WO06121811, WO07018067, WO07108362, WO07115970, WO07115981, WO08035571, WO2002015645, WO2003040257, WO2005019373, WO2006056418, WO2008054584, WO2008078800, WO2008096609, WO2008101842, WO2009000673, WO2009050281, WO2009100991, WO2010028151, WO2010054731, WO2010086089, WO2010118029, WO2011044988, WO2011051404, WO2011107491, WO2012020327, WO2012163471, WO2013094620, WO2013107487, WO2013174471, WO2014007565, WO2014008982, WO2014023377, WO2014024131, WO2014031977, WO2014038456, WO2014112450,

HBL:

A hole blocking layer (HBL) may be used to reduce the number of holes and/or excitons that leave the emissive layer. The presence of such a blocking layer in a device may result in substantially higher efficiencies and/or longer lifetime as compared to a similar device lacking a blocking layer. Also, a blocking layer may be used to confine emission to a desired region of an OLED. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than the emitter closest to the HBL interface. In some embodiments, the HBL material has a lower HOMO (further from the vacuum level) and or higher triplet energy than one or more of the hosts closest to the HBL interface.

In one aspect, compound used in HBL contains the same molecule or the same functional groups used as host described above.

In another aspect, compound used in HBL contains at least one of the following groups in the molecule:

wherein k is an integer from 1 to 20; L¹⁰¹ is an another ligand, k′ is an integer from 1 to 3.

ETL:

Electron transport layer (ETL) may include a material capable of transporting electrons. Electron transport layer may be intrinsic (undoped), or doped. Doping may be used to enhance conductivity. Examples of the ETL material are not particularly limited, and any metal complexes or organic compounds may be used as long as they are typically used to transport electrons.

In one aspect, compound used in ETL contains at least one of the following groups in the molecule:

wherein R¹⁰¹ is selected from the group consisting of hydrogen, deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acids, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof, when it is aryl or heteroaryl, it has the similar definition as Ar's mentioned above. Ar¹ to Ar³ has the similar definition as Ar's mentioned above. k is an integer from 1 to 20. X¹⁰¹ to X¹⁰⁸ is selected from C (including CH) or N.

In another aspect, the metal complexes used in ETL include, but are not limited to the following general formula:

wherein (O—N) or (N—N) is a bidentate ligand, having metal coordinated to atoms O, N or N, N; L¹⁰¹ is another ligand; k′ is an integer value from 1 to the maximum number of ligands that may be attached to the metal.

Non-limiting examples of the ETL materials that may be used in an OLED in combination with materials disclosed herein are exemplified below together with references that disclose those materials: CN103508940, EP01602648, EP01734038, EP01956007, JP2004-022334, JP2005149918, JP2005-268199, KR0117693, KR20130108183, US20040036077, US20070104977, US2007018155, US20090101870, US20090115316, US20090140637, US20090179554, US2009218940, US2010108990, US2011156017, US2011210320, US2012193612, US2012214993, US2014014925, US2014014927, US20140284580, U.S. Pat. Nos. 6,656,612, 8,415,031, WO2003060956, WO2007111263, WO2009148269, WO2010067894, WO2010072300, WO2011074770, WO2011105373, WO2013079217, WO2013145667, WO2013180376, WO2014104499, WO2014104535,

Charge Generation Layer (CGL)

In tandem or stacked OLEDs, the CGL plays an essential role in the performance, which is composed of an n-doped layer and a p-doped layer for injection of electrons and holes, respectively. Electrons and holes are supplied from the CGL and electrodes. The consumed electrons and holes in the CGL are refilled by the electrons and holes injected from the cathode and anode, respectively; then, the bipolar currents reach a steady state gradually. Typical CGL materials include n and p conductivity dopants used in the transport layers.

In any above-mentioned compounds used in each layer of the OLED device, the hydrogen atoms can be partially or fully deuterated. Thus, any specifically listed substituent, such as, without limitation, methyl, phenyl, pyridyl, etc. encompasses undeuterated, partially deuterated, and fully deuterated versions thereof. Similarly, classes of substituents such as, without limitation, alkyl, aryl, cycloalkyl, heteroaryl, etc. also encompass undeuterated, partially deuterated, and fully deuterated versions thereof.

EXPERIMENTAL Synthetic Scheme of Inventive Example 1 [Compound No. 15]

Step 1. Synthesis of 2-chloro-1-fluoro-3-methoxybenzene (2)

In a round bottomed flask open to the atmosphere, 2-chloro-3-fluorophenol (5 g, 34 mmol), iodomethane (2.23 mL, 36 mmol) and potassium carbonate (5.19 g, 38 mmol) were stirred in acetone (68 ml) at reflux for 16 hours. The reaction mixture was cooled to ambient temperature and diluted with water (200 mL). Sodium hydroxide pellets (0.2 g, 5 mmol) were added and the reaction mixture stirred for 5 minutes before the acetone was removed under reduced pressure. The reaction mixture was extracted with ethyl acetate (3×150 mL) and the combined organic extracts were dried over sodium sulphate, which was removed by filtration and the organic phase concentrated in vacuo to afford the title compound as a light yellow oil (5.49 g, >99% yield). This material was used in the subsequent step without further purification. ¹H NMR (396 MHz, CDCl₃) δ 7.18 (dt, 1H), 6.79 (dt, 1H), 6.73 (dt, 1H), 3.92 (s, 3H) ppm.

Step 2. Synthesis of 1-bromo-3-chloro-2-fluoro-4-methoxybenzene (3)

At 0° C., bromine (1.68 mL, 33 mmol) was added to 2-chloro-1-fluoro-3-methoxybenzene (5.45 g, 34 mmol) (2), followed by dichloromethane (50 mL). The homogeneous reaction mixture was stirred at ambient temperature for 3 hours, thereafter saturated aqueous sodium hydrogen carbonate solution (50 mL) was introduced and the biphasic reaction mixture was stirred for 16 hours at ambient temperature. The organic phase was isolated and the aqueous phase was washed with dichloromethane (3×10 mL) and the combined organic phases were dried over sodium sulphate. The drying agent was removed by filtration and the mother liquors were concentrated in vacuo to give the title compound (3) as a light yellow solid (7.52 g, 97% yield). This material was used in subsequent steps without further purification.

Step 3. Synthesis of 1-(6-bromo-2-chloro-3-methoxyphenoxy)naphthalene (5)

In a round bottomed flask under a continuous positive pressure of nitrogen, 1-bromo-3-chloro-2-fluoro-4-methoxybenzne (36.4 g, 152 mmol) (3), naphthalene-1-ol (26.3 g, 182 mmol) and caesium carbonate (74.3 g, 228 mmol) were added to N,N-dimethylacetamide (304 mL) and the reaction mixture heated to 130° C. for 16 hours. The reaction mixture was cooled to ambient temperature and the solvent removed under reduced pressure. The crude material was loaded onto silica and purified by column chromatography (Biotage, SNAP, Ultra) using a gradient of dichloromethane in heptane as the eluting solvent system. Product containing fractions were combined to give the target compound (5) as an off white solid (39.5 g, 72% yield). ¹H-NMR (396 MHz, CDCl₃): δ 7.36 (t, 2H), 7.16 (t, 1H), 7.12 (t, 1H), 7.01 (d, 2H), 6.80 (d, 1H), 2.57 (2, 3H) ppm.

Step 4. Synthesis of 10-chloro-9-methoxynaphtho[1,2-b]benzofuran (6)

In a round bottomed flask under an atmosphere of nitrogen, a solution of 1-(6-bromo-2-chloro-3-methoxyphenoxy)naphthalene (39 g, 107 mmol) (5) in xylenes (429 mL) was charged with tri-tert-butylphosphonium tetrafluoroborate (6.22 g, 21 mmol) and 1,8-diazabicycloundec-7-ene (26 mL, 172 mmol). The reaction mixture was rigorously degassed with bubbling nitrogen for 30 minutes followed by the addition of palladium(II)acetate (1.93 g, 9 mmol) and further bubbling with nitrogen for 15 minutes. The reaction mixture was heated to 140° C., with stirring, for 16 hours, whereupon a further portion of palladium(II)acetate (0.96 g, 4 mmol), tri-tert-butylphosphonium tetrafluoroborate (3.11 g, 11 mmol) and 1,8-diazabicycloundec-7-ene (13 mL, 86 mmol) was added. The reaction mixture was then heated at 140° C. for a further 24 hours before the xylenes were removed in vacuo and the crude material partitioned between dichloromethane (200 mL and water (200 mL). The organic phase was isolated and the aqueous phase washed with dichloromethane (2×100 mL). The combined organic fractions were dried over sodium sulphate, which was removed by filtration and the organic solvent removed by evaporation under reduced pressure. The material was then dry-loaded onto silica and isolated by column chromatography (40:60 dichloromethane:heptane). Product-containing fractions were combined and evaporated to give the target compound (6) as an off-white solid (17.42 g, 57% yield). ¹H-NMR (396 MHz, CDCl3): δ 8.49 (d, 1H), 7.98 (d, 1H), 7.92 (d, 1H), 7.79 (t, 2H), 7.65 (td, 1H), 7.56 (td, 1H), 7.04 (d, 1H), 4.03 (s, 3H) ppm Step 5. Synthesis of 2-(9-methoxynaphtho[1,2-b]benzofuran-10yl)pyridine (8).

Under a positive flow of nitrogen a flame-dried three necked round bottomed flask was charged with 10-chloro-9-methoxynaphtho[1,2-b]benzofuran (9.5 g, 34 mmol) (6), XPhos (3.2 g, 7 mmol) and tris(dibenzylieneacetonel)dipalladium(0) (1.54 g, 2 mmol). The flask was evacuated and backfilled with nitrogen three times before anhydrous tetrahydrofuran (112 mL) was introduced via syringe. Hereafter, a solution of pyridine-2-yl zinc(II)bromide (0.5 M in tetrahydrofuran, 101 mL, 50 mmol) was added dropwise via syringe. The reaction mixture was heated to reflux for 2.5 hours. The reaction mixture was cooled to 0 C and quenched with saturated aqueous ammonium chloride solution (100 mL). A solid material was formed, which required addition of ammonia solution in methanol (7 M, 50 mL) to induce salvation. Any subsequent insoluble material was then removed by filtration and the filtrates were evaporated to remove the organic solvents. The aqueous phase was then extracted with dichloromethane (3×150 mL) and the combined organic phases were dried over sodium sulfate, which was removed by filtration and the organic phase concentrated in vacuo. The crude material was dry loaded onto silica and isolated by column chromatography (Biotage, SNAP 340 g Ultra) using a gradient of tetrahydrofuran in heptanes as the eluent. The product eluted between 30 and 35% tetrahydrofuran content. The product containing fractions were combined and evaporated to give the target compound (8) as a white solid (8.69 g, 80% yield). ¹H-NMR (396 MHz, CDCl₃) δ 8.90 (d, 1H), 8.28 (d, 1H), 7.96 (dd, 3H, 7.87 (dt, 1H), 7.49-7.54 (m, 2H), 7.39 (ddd, 1H), 7.12 (d, 1H) 3.92 (s, 3H) ppm.

Step 6. Synthesis of 10-(pyridine-2-yl)naphtha[1,2-b]benzofuran-9-ol

In a three necked flask under nitrogen, 2-(9-methoxynaphtho[1,2-b]benzofuran-10-yl)pyridine (8.7 g, 27 mmol) (8) was dissolved in dry dichloromethane (108 mL) and the solution was cooled to 0° C. Boron tribromide solution (1 M in dichloromethane, 54 mL, 54 mmol) was added slowly via syringe at such as rate as to maintain the temperature below 10° C. and the reaction mixture was allowed to warm to room temperature over 16 hours. The reaction mixture was quenched with water and methanol, the resultant bright yellow solid suspension was then concentrated under reduced pressure to give a viscous solid which was then dissolved in methanol (500 mL). In order to remove the boron complexation, sodium hydroxide pellets (excess) were added cautiously, before dichloromethane (500 mL) and water (500 mL) were added and the organic phase was isolated. The aqueous phase was extracted with dichloromethane (3×500 mL) and the combined fractions were dried over sodium sulphate. The drying agent was removed by filtration and the filtrates concentrated in vacuo to give 25 g crude product. This crude material (together with different batches of equal quality from small trials) was dissolved in dichloromethane and dry loaded onto silica before purification by column chromatography (Biotage SNAP 340 g Ultra) using a gradient of ethyl acetate in heptanes as the eluent (0% to 60% in 15 CV, product eluted at 40% of the mobile phase). Fractions containing pure product by TLC were combined and the solvent removed in vacuo to afford 10-(pyridine-2-yl)naphtha[1,2-b]benzofuran-9-ol (9) as a white solid (9.53 g). ¹H-NMR (396 MHz, CDCl₃) δ 9.06 (d, 1H), 8.60 (d, 1H), 8.42 (d, 1H), 8.05 (td, 1H), 7.98 (d, 1H), 7.92 (d, 1H), 7.87 (d, 1H), 7.77 (d, 1H), 7.65 (t, 1H), 7.53 (t, 1H), 7.35 (dd, 1H), 7.11 (d, 1H) ppm. HPLC (40 min_UDC, neutral) RT 13.517 (99.748%).

Step 7. Synthesis of Compound 5

Zinc 10-(pyridin-2-yl)naphtho[1,2-b]benzofuran-9-olate

To a room temperature suspension of 10-(pyridin-2-yl)naphtho[1,2-b]benzofuran-9-ol (8.5 g, 27.31 mmol, 2.0 equiv) (9) in tetrahydrofuran (100 mL) under a nitrogen atmosphere was added 15 wt % diethylzinc in toluene (12.28 mL, 13.65 mmol, 1.0 equiv) dropwise and the reaction mixture stirred for 2 hours. The suspension was filtered, the solid washed with toluene (2×10 mL) and tetrahydrofuran (2×10 mL) then dried in a vacuum oven at 50° C. for 4 hours to give zinc 10-(pyridin-2-yl)naphtho[1,2-b]benzofuran-9-olate (7.95 g, 85% yield), Compound No. 5, as a yellow solid.

Synthesis of Comparative Example 1

Bis[((pyridin-1-yl)-2-yl)phenoxy]zinc

A 15 wt % solution of diethylzinc in toluene (24.4 mL, 27.16 mmol, 1.0 equiv) was added dropwise to a solution of 2-(pyridin-2-yl)phenol (9.3 g, 54.32 mmol, 2.0 equiv) in tetrahydrofuran (100 mL) at room temperature, using a water-bath as a heat sink. The reaction mixture was stirred for 2 hours at room temperature under nitrogen. The suspension was filtered, the solid washed with toluene (3×5 mL) and tetra-hydrofuran (3×5 mL) then dried in a vacuum oven at 50° C. for 4 hours to give bis[((pyridin-1-yl)-2-yl)phenoxy]zinc (11 g, 100% yield) as a light yellow solid.

TABLE II DFT Calculation results of Select Compounds of Formula I. Carrier gap (LUMO- Cpd. HOMO LUMO HOMO) T1 No. Structure (ev) (ev) (ev) (nm) Comp. Ex. 1

−5.549 −1.758 3.791 478  1

−5.41 −1.85 3.54 564  15

−5.378 −1.853 3.525 539  29

−5.349 −1.878 3.471 564 331

−5.365 −1.871 3.494 547 319

−5.404 −1.859 3.545 535 313

−5.436 −1.872 3.564 546 325

−5.388 −1.873 3.515 558 343

−5.402 −1.875 3.527 548 337

−5.389 −1.88 3.509 554 355

−5.41 −1.886 3.524 539 349

−5.407 −1.884 3.523 535 361

−5.406 −1.876 3.53 531 367

−5.445 −1.884 3.561 525 368

−5.299 −1.839 3.46 534

-   -   HOMO, LUMO, singlet energy S1, and triplet energy T1 were         calculated within the Gaussian16 software package using the         B3LYP hybrid functional set and cep-31G basis set. S1 and T1         were obtained using TDDFT at the optimized ground state         geometry. A continuum solvent model was applied to simulate         tetrahydrofuran solvent.

Efficient utilization of high energy excitons is one of the most important issues for electroluminescence (EL) because of the high sensitivity of these excitons to various quenching pathways. In particular, hosts for red phosphorescent OLEDS (PHOLED) has been of interest in recent years for fundamental studies of structure-property correlations and the corresponding approaches for and select modifications to such hosts.

Under the conventional strategy; two prerequisites for molecular design should be considered: (1) only host with high-enough T1 can be considered; and (2) minimum carrier gap will be highly desirable to achieve good carrier injection and transportation. For each of the compounds of Formula I in Table II: DFT Calculations, the T1 energy is between 525 nm to 574 nm; which is high enough to support red phosphorescent OLEDS. Furthermore; each of the tested compounds has a carrier gap between 3.46 eV to 3.56 eV; which is much smaller than the carrier gap of comparative example. 1, 3.79 eV. Minimum carrier gap is highly desirable to achieve good carrier injection and transportation.

The calculations obtained with the above-identified DFT functional set and basis set are theoretical. Computational composite protocols, such as the Gaussian09 with B3LYP and CEP-31G protocol used herein, rely on the assumption that electronic effects are additive and, therefore, larger basis sets can be used to extrapolate to the complete basis set (CBS) limit. However, when the goal of a study is to understand variations in HOMO, LUMO, Si, Ti, bond dissociation energies, etc. over a series of structurally-related compounds, the additive effects are expected to be similar. Accordingly, while absolute errors from using the B3LYP may be significant compared to other computational methods, the relative differences between the HOMO, LUMO, Si, Ti, and bond dissociation energy values calculated with B3LYP protocol are expected to reproduce experiment quite well. See, e.g., Hong et al., Chem. Mater. 2016, 28, 5791-98, 5792-93 and Supplemental Information (discussing the reliability of DFT calculations in the context of OLED materials). Moreover, with respect to iridium or platinum complexes that are useful in the OLED art, the data obtained from DFT calculations correlates very well to actual experimental data. See Tavasli et al., J. Mater. Chem. 2012, 22, 6419-29, 6422 (Table 3) (showing DFT calculations closely correlating with actual data for a variety of emissive complexes); Morello, G. R., J. Mol. Model. 2017, 23:174 (studying of a variety of DFT functional sets and basis sets and concluding the combination of B3LYP and CEP-31G is particularly accurate for emissive complexes).

It is understood that the various embodiments described herein are by way of example only, and are not intended to limit the scope of the invention. For example, many of the materials and structures described herein may be substituted with other materials and structures without deviating from the spirit of the invention. The present invention as claimed may therefore include variations from the particular examples and preferred embodiments described herein, as will be apparent to one of skill in the art. It is understood that various theories as to why the invention works are not intended to be limiting. 

We claim:
 1. A compound of Formula (L_(A))_(n)-M-(L_(C))_(m), wherein the ligand L_(A) is of Formula I, and ligand L_(C) is selected from Formula I that is different than ligand L_(A), a monoanionic bidentate ligand, or a monanionic monodentate ligand; M is a metal; and n is 1 or 2, and m is 0, 1 or 2;

wherein Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B; Z is selected from O or S; Z¹ is selected from a carbene C or N; and Z² is selected from C or N; R^(A) and R^(B) represent mono to the maximum allowable substitution, or no substitution; each R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent groups of R^(A) or R^(B) can join to form a carbocyclic ring or a heterocyclic ring, which is optionally substituted; or optionally R^(A) or R^(B) can join with the ligand L_(C) to form a multidentate ligand; with the proviso that two adjacent ring carbons of Ring B form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons,

wherein X is selected from NR^(N), O, S, or Se; wherein R^(N) is selected from the group consisting of hydrogen, deuterium, alkyl, cycloalkyl, heteroalkyl, aryl, heteroaryl, and combinations thereof; Y¹, Y², Y³, and Y⁴ are independently CR^(Y1), CR^(Y2), CR^(Y3), and CR^(Y4), respectively, or N, and Ring D has no more than two nitrogen ring atoms; R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently selected from the group hydrogen, deuterium, fluorine, alkyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, acyl, ester, nitrile, isonitrile, sulfanyl, and combinations thereof; or any two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can join to form a fused 6-member ring, or a fused 5-member ring, each of which can be carbocyclic or heterocyclic, and aromatic or non-aromatic, each of which is optionally substituted.
 2. The compound of claim 1, wherein R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, sulfanyl, and combinations thereof.
 3. The compound of claim 1, wherein the ligand L_(A) is represented by Formula II or Formula

wherein Ring A is 5-member or 6-member heteroaryl ring; wherein for Formula II; X₁ is selected from CR^(1A) or N, X₂ is selected from CR^(2A), N or NR^(N), and X₃ is C or N; wherein if X₃ is N then X₂ is CR^(2A); wherein for Formula III, X₂ is CR^(2A), N or NR^(N); and R^(1A) and R^(2A) are represented by R^(A); each R^(B) is represented by R¹, R², R³, and R⁴; wherein any two adjacent R¹, R², R³, and R⁴ can join to form a ring of formula D, with the proviso that at least one of the adjacent groups selected from R¹ and R², R² and R³, or R³ and R⁴, do join to form a group of formula D.
 4. The compound of claim 1, wherein R¹ and R² join to form the group of formula D.
 5. The compound of claim 1, wherein R² and R³ join to form the group of formula D.
 6. The compound of claim 1, wherein M is metal selected from the group consisting of Ag, Au, Be, a first row transition metal; and a Group IIIA to VA element selected from Al, Ga, In, Sn, Tl, Pb, or Bi.
 7. The compound of claim 1, wherein M is selected from Zn, Al, Be, or Sn.
 8. The compound of claim 1, wherein the Ring A is selected from the group consisting of pyridyl, pyrazinyl, pyrimidyl, and imidazole.
 9. The compound of claim 1, wherein one or two of the adjacent groups selected from R^(Y1) and R^(Y2), R^(Y2) and R^(Y3), or R^(Y3) and R^(Y4) join to form a fused 6-member aromatic ring, which is optionally substituted or fuses to another aromatic ring.
 10. The compound of claim 3, wherein for the compounds of Formula II, X₂ is CR^(2A), and R^(2A) and an adjacent R^(A) join together to form a fused aromatic ring.
 11. The compound of claim 1, wherein the ligand L_(A) is optionally linked with another ligand L_(A), which is the same or different, or the ligand L_(C) to form a tridentate or tetradentate ligand.
 12. The compound of claim 1, being a homoleptic compound of Formula IVA or Formula IVB


13. The compound of claim 1, being a homoleptic compound of Formula VA or Formula VB

wherein W¹, W², W³, and W⁴ are independently selected from CR^(W) or N, with no more than two of W¹, W², W³, and W⁴ being N, wherein the dotted lines from ring carbons of ring W represent the fusion of ring atoms to the adjacent ring, and each R^(W) is independently selected from hydrogen, deuterium, fluorine, alkyl, cycloalkyl, silyl, aryl, heteroaryl, and combinations thereof, or optionally, two adjacent R^(W) join to form a fused aryl or heteroaryl ring.
 14. The compound of claim 3, wherein for the compound of Formula II; X₁, X₂ and X₃ are each C, and Z is O to provide a compound of Formula IIA,

wherein the compound of Formula IIA selected from the group consisting of: No. R^(A) R¹/R² R³ R⁴ n Me
 1. H 1,2-G1 H H 2 Zn
 2. H 2,1-G1 H H 2 Zn
 3. H 1,2-G1 Ph H 2 Zn
 4. H 2,1-G1 Ph H 2 Zn
 5. H 1,2-G1 H Ph 2 Zn
 6. H 2,1-G1 H Ph 2 Zn
 7. 3-Ph 1,2-G1 H H 2 Zn
 8. 3-Ph 2,1-G1 H H 2 Zn
 9. 3-Ph 1,2-G1 Ph H 2 Zn
 10. 3-Ph 2,1-G1 Ph H 2 Zn
 11. 4-Ph 1,2-G1 H H 2 Zn
 12. 4-Ph 2,1-G1 H H 2 Zn
 13. 4-Ph 1,2-G1 Ph H 2 Zn
 14. 4-Ph 2,1-G1 Ph H 2 Zn
 15. H 1,2-G2 H H 2 Zn
 16. H 2,1-G2 H H 2 Zn
 17. H 1,2-G2 Ph H 2 Zn
 18. H 2,1-G2 Ph H 2 Zn
 19. H 1,2-G2 H Ph 2 Zn
 20. H 2,1-G2 H Ph 2 Zn
 21. 3-Ph 1,2-G2 H H 2 Zn
 22. 3-Ph 2,1-G2 H H 2 Zn
 23. 3-Ph 1,2-G2 Ph H 2 Zn
 24. 3-Ph 2,1-G2 Ph H 2 Zn
 25. 4-Ph 1,2-G2 H H 2 Zn
 26. 4-Ph 2,1-G2 H H 2 Zn
 27. 4-Ph 1,2-G2 Ph H 2 Zn
 28. 4-Ph 2,1-G2 Ph H 2 Zn
 29. H 1,2-G3 H H 2 Zn
 30. H 2,1-G3 H H 2 Zn
 31. H 1,2-G3 Ph H 2 Zn
 32. H 2,1-G3 Ph H 2 Zn
 33. H 1,2-G3 H Ph 2 Zn
 34. H 2,1-G3 H Ph 2 Zn
 35. 3-Ph 1,2-G3 H H 2 Zn
 36. 3-Ph 2,1-G3 H H 2 Zn
 37. 3-Ph 1,2-G3 Ph H 2 Zn
 38. 3-Ph 2,1-G3 Ph H 2 Zn
 39. 4-Ph 1,2-G3 H H 2 Zn
 40. 4-Ph 2,1-G3 H H 2 Zn
 41. 4-Ph 1,2-G3 Ph H 2 Zn
 42. 4-Ph 2,1-G3 Ph H 2 Zn No. R^(A) R¹ R²/R³ R⁴ n M
 43. H H 2,3-G1 H 2 Zn
 44. H H 3,2-G1 H 2 Zn
 45. 3-Ph H 2,3-G1 H 2 Zn
 46. 3-Ph H 3,2-G1 H 2 Zn
 47. 3-Ph H 2,3-G1 H 2 Zn
 48. 4-Ph H 3,2-G1 H 2 Zn
 49. H H 2,3-G2 H 2 Zn
 50. H H 3,2-G2 H 2 Zn
 51. 3-Ph H 2,3-G2 H 2 Zn
 52. 3-Ph H 3,2-G2 H 2 Zn
 53. 3-Ph H 2,3-G2 H 2 Zn
 54. 4-Ph H 3,2-G2 H 2 Zn
 55. H H 2,3-G3 H 2 Zn
 56. H H 3,2-G3 H 2 Zn
 57. 3-Ph H 2,3-G3 H 2 Zn
 58. 3-Ph H 3,2-G3 H 2 Zn
 59. 3-Ph H 2,3-G3 H 2 Zn
 60. 4-Ph H 3,2-G3 H 2 Zn No. R^(A) R¹ R² R³/R⁴ n M
 61. H H H 3,4-G1 2 Zn
 62. H H H 4,3-G1 2 Zn
 63. 3-Ph H H 3,4-G1 2 Zn
 64. 3-Ph H H 4,3-G1 2 Zn
 65. 3-Ph H H 3,4-G1 2 Zn
 66. H H H 4,3-G1 2 Zn
 67. H H H 3,4-G2 2 Zn
 68. 3-Ph H H 4,3-G2 2 Zn
 69. 3-Ph H H 3,4-G2 2 Zn
 70. 3-Ph H H 4,3-G2 2 Zn
 71. 4-Ph H H 3,4-G2 2 Zn
 72. H H H 4,3-G2 2 Zn
 73. H H H 3,4-G3 2 Zn
 74. 3-Ph H H 4,3-G3 2 Zn
 75. 3-Ph H H 3,4-G3 2 Zn
 76. 3-Ph H H 4,3-G3 2 Zn
 77. 4-Ph H H 3,4-G3 2 Zn
 78. H H H 4,3-G3 2 Zn No. R^(A) R¹/R² R³ R⁴ n M
 79. H 1,2-G1 H H 2 Be
 80. H 2,1-G1 H H 2 Be
 81. H 1,2-G1 Ph H 2 Be
 82. H 2,1-G1 Ph H 2 Be
 83. H 1,2-G1 H Ph 2 Be
 84. H 2,1-G1 H Ph 2 Be
 85. 3-Ph 1,2-G1 H H 2 Be
 86. 3-Ph 2,1-G1 H H 2 Be
 87. 3-Ph 1,2-G1 Ph H 2 Be
 88. 3-Ph 2,1-G1 Ph H 2 Be
 89. 4-Ph 1,2-G1 H H 2 Be
 90. 4-Ph 2,1-G1 H H 2 Be
 91. 4-Ph 1,2-G1 Ph H 2 Be
 92. 4-Ph 2,1-G1 Ph H 2 Be
 93. H 1,2-G2 H H 2 Be
 94. H 2,1-G2 H H 2 Be
 95. H 1,2-G2 Ph H 2 Be
 96. H 2,1-G2 Ph H 2 Be
 97. H 1,2-G2 H Ph 2 Be
 98. H 2,1-G2 H Ph 2 Be
 99. 3-Ph 1,2-G2 H H 2 Be
 100. 3-Ph 2,1-G2 H H 2 Be
 101. 3-Ph 1,2-G2 Ph H 2 Be
 102. 3-Ph 2,1-G2 Ph H 2 Be
 103. 4-Ph 1,2-G2 H H 2 Be
 104. 4-Ph 2,1-G2 H H 2 Be
 105. 4-Ph 1,2-G2 Ph H 2 Be
 106. 4-Ph 2,1-G2 Ph H 2 Be
 107. H 1,2-G2 H H 2 Be
 108. H 2,1-G3 H H 2 Be
 109. H 1,2-G3 Ph H 2 Be
 110. H 2,1-G3 Ph H 2 Be
 111. H 1,2-G3 H Ph 2 Be
 112. H 2,1-G3 H Ph 2 Be
 113. 3-Ph 1,2-G3 H H 2 Be
 114. 3-Ph 2,1-G3 H H 2 Be
 115. 3-Ph 1,2-G3 Ph H 2 Be
 116. 3-Ph 2,1-G3 Ph H 2 Be
 117. 4-Ph 1,2-G3 H H 2 Be
 118. 4-Ph 2,1-G3 H H 2 Be
 119. 4-Ph 1,2-G3 Ph H 2 Be
 120. 4-Ph 2,1-G3 Ph H 2 Be No. R^(A) R¹ R²/R³ R⁴ n M
 121. H H 2,3-G1 H 2 Be
 122. H H 3,2-G1 H 2 Be
 123. 3-Ph H 2,3-G1 H 2 Be
 124. 3-Ph H 3,2-G1 H 2 Be
 125. 3-Ph H 2,3-G1 H 2 Be
 126. 4-Ph H 3,2-G1 H 2 Be
 127. H H 2,3-G2 H 2 Be
 128. H H 3,2-G2 H 2 Be
 129. 3-Ph H 2,3-G2 H 2 Be
 130. 3-Ph H 3,2-G2 H 2 Be
 131. 3-Ph H 2,3-G2 H 2 Be
 132. 4-Ph H 3,2-G2 H 2 Be
 133. H H 2,3-G3 H 2 Be
 134. H H 3,2-G3 H 2 Be
 135. 3-Ph H 2,3-G3 H 2 Be
 136. 3-Ph H 3,2-G3 H 2 Be
 137. 3-Ph H 2,3-G3 H 2 Be
 138. 4-Ph H 3,2-G3 H 2 Be No. R^(A) R¹ R² R³/R⁴ n M
 139. H H H 3,4-G1 2 Be
 140. H H H 4,3-G1 2 Be
 141. 3-Ph H H 3,4-G1 2 Be
 142. 3-Ph H H 4,3-G1 2 Be
 143. 3-Ph H H 3,4-G1 2 Be
 144. H H H 4,3-G1 2 Be
 145. H H H 3,4-G2 2 Be
 146. 3-Ph H H 4,3-G2 2 Be
 147. 3-Ph H H 3,4-G2 2 Be
 148. 3-Ph H H 4,3-G2 2 Be
 149. 4-Ph H H 3,4-G2 2 Be
 150. H H H 4,3-G2 2 Be
 151. H H H 3,4-G3 2 Be
 152. 3-Ph H H 4,3-G3 2 Be
 153. 3-Ph H H 3,4-G3 2 Be
 154. 3-Ph H H 4,3-G3 2 Be
 155. 4-Ph H H 3,4-G3 2 Be
 156. H H H 4,3-G3 2 Be No. R^(A) R¹/R² R³ R⁴ n M
 157. H 1,2-G1 H H 3 Al
 158. H 2,1-G1 H H 3 Al
 159. H 1,2-G1 Ph H 3 Al
 160. H 2,1-G1 Ph H 3 Al
 161. H 1,2-G1 H Ph 3 Al
 162. H 2,1-G1 H Ph 3 Al
 163. 3-Ph 1,2-G1 H H 3 Al
 164. 3-Ph 2,1-G1 H H 3 Al
 165. 3-Ph 1,2-G1 Ph H 3 Al
 166. 3-Ph 2,1-G1 Ph H 3 Al
 167. 4-Ph 1,2-G1 H H 3 Al
 168. 4-Ph 2,1-G1 H H 3 Al
 169. 4-Ph 1,2-G1 Ph H 3 Al
 170. 4-Ph 2,1-G1 Ph H 3 Al
 171. H 1,2-G2 H H 3 Al
 172. H 2,1-G2 H H 3 Al
 173. H 1,2-G2 Ph H 3 Al
 174. H 2,1-G2 Ph H 3 Al
 175. H 1,2-G2 H Ph 3 Al
 176. H 2,1-G2 H Ph 3 Al
 177. 3-Ph 1,2-G2 H H 3 Al
 178. 3-Ph 2,1-G2 H H 3 Al
 179. 3-Ph 1,2-G2 Ph H 3 Al
 180. 3-Ph 2,1-G2 Ph H 3 Al
 181. 4-Ph 1,2-G2 H H 3 Al
 182. 4-Ph 2,1-G2 H H 3 Al
 183. 4-Ph 1,2-G2 Ph H 3 Al
 184. 4-Ph 2,1-G2 Ph H 3 Al
 185. H 1,2-G3 H H 3 Al
 186. H 2,1-G3 H H 3 Al
 187. H 1,2-G3 Ph H 3 Al
 188. H 2,1-G3 Ph H 3 Al
 189. H 1,2-G3 H Ph 3 Al
 190. H 2,1-G3 H Ph 3 Al
 191. 3-Ph 1,2-G3 H H 3 Al
 192. 3-Ph 2,1-G3 H H 3 Al
 193. 3-Ph 1,2-G3 Ph H 3 Al
 194. 3-Ph 2,1-G3 Ph H 3 Al
 195. 4-Ph 1,2-G3 H H 3 Al
 196. 4-Ph 2,1-G3 H H 3 Al
 197. 4-Ph 1,2-G3 Ph H 3 Al
 198. 4-Ph 2,1-G3 Ph H 3 Al No. R^(A) R¹ R²/R³ R⁴ n M
 199. H H 2,3-G1 H 3 Al
 200. H H 3,2-G1 H 3 Al
 201. 3-Ph H 2,3-G1 H 3 Al
 202. 3-Ph H 3,2-G1 H 3 Al
 203. 3-Ph H 2,3-G1 H 3 Al
 204. 4-Ph H 3,2-G1 H 3 Al
 205. H H 2,3-G2 H 3 Al
 206. H H 3,2-G2 H 3 Al
 207. 3-Ph H 2,3-G2 H 3 Al
 208. 3-Ph H 3,2-G2 H 3 Al
 209. 3-Ph H 2,3-G2 H 3 Al
 210. 4-Ph H 3,2-G2 H 3 Al
 211. H H 2,3-G3 H 3 Al
 212. H H 3,2-G3 H 3 Al
 213. 3-Ph H 2,3-G3 H 3 Al
 214. 3-Ph H 3,2-G3 H 3 Al
 215. 3-Ph H 2,3-G3 H 3 Al
 216. 4-Ph H 3,2-G3 H 3 Al No. R^(A) R¹ R² R³/R⁴ n M
 217. H H H 3,4-G1 3 Al
 218. H H H 4,3-G1 3 Al
 219. 3-Ph H H 3,4-G1 3 Al 220 3-Ph H H 4,3-G1 3 Al
 221. 3-Ph H H 3,4-G1 3 Al
 222. H H H 4,3-G1 3 Al
 223. H H H 3,4-G2 3 Al
 224. 3-Ph H H 4,3-G2 3 Al
 225. 3-Ph H H 3,4-G2 3 Al
 226. 3-Ph H H 4,3-G2 3 Al
 227. 4-Ph H H 3,4-G2 3 Al
 228. H H H 4,3-G2 3 Al
 229. H H H 3,4-G3 3 Al
 230. 3-Ph H H 4,3-G3 3 Al
 231. 3-Ph H H 3,4-G3 3 Al
 232. 3-Ph H H 4,3-G3 3 Al
 233. 4-Ph H H 3,4-G3 3 Al
 234. H H H 4,3-G3 3 Al No. R^(A) R¹/R² R³ R⁴ n M
 235. H 1,2-G1 H H 3 Bi
 236. H 2,1-G1 H H 3 Bi
 237. H 1,2-G1 Ph H 3 Bi
 238. H 2,1-G1 Ph H 3 Bi
 239. H 1,2-G1 H Ph 3 Bi
 240. H 2,1-G1 H Ph 3 Bi
 241. 3-Ph 1,2-G1 H H 3 Bi
 242. 3-Ph 2,1-G1 H H 3 Bi
 243. 3-Ph 1,2-G1 Ph H 3 Bi
 244. 3-Ph 2,1-G1 Ph H 3 Bi
 245. 4-Ph 1,2-G1 H H 3 Bi
 246. 4-Ph 2,1-G1 H H 3 Bi
 247. 4-Ph 1,2-G1 Ph H 3 Bi
 248. 4-Ph 2,1-G1 Ph H 3 Bi
 249. H 1,2-G2 H H 3 Bi
 250. H 2,1-G2 H H 3 Bi
 251. H 1,2-G2 Ph H 3 Bi
 252. H 2,1-G2 Ph H 3 Bi
 253. H 1,2-G2 H Ph 3 Bi
 254. H 2,1-G2 H Ph 3 Bi
 255. 3-Ph 1,2-G2 H H 3 Bi
 256. 3-Ph 2,1-G2 H H 3 Bi
 257. 3-Ph 1,2-G2 Ph H 3 Bi
 258. 3-Ph 2,1-G2 Ph H 3 Bi
 259. 4-Ph 1,2-G2 H H 3 Bi
 260. 4-Ph 2,1-G2 H H 3 Bi
 261. 4-Ph 1,2-G2 Ph H 3 Bi
 262. 4-Ph 2,1-G2 Ph H 3 Bi
 263. H 1,2-G3 H H 3 Bi
 264. H 2,1-G3 H H 3 Bi
 265. H 1,2-G3 Ph H 3 Bi
 266. H 2,1-G3 Ph H 3 Bi
 267. H 1,2-G3 H Ph 3 Bi
 268. H 2,1-G3 H Ph 3 Bi
 269. 3-Ph 1,2-G3 H H 3 Bi
 270. 3-Ph 2,1-G3 H H 3 Bi
 271. 3-Ph 1,2-G3 Ph H 3 Bi
 272. 3-Ph 2,1-G3 Ph H 3 Bi
 273. 4-Ph 1,2-G3 H H 3 Bi
 274. 4-Ph 2,1-G3 H H 3 Bi
 275. 4-Ph 1,2-G3 Ph H 3 Bi
 276. 4-Ph 2,1-G3 Ph H 3 Bi No. R^(A) R¹ R²/R³ R⁴ n M
 277. H H 2,3-G1 H 3 Bi
 278. H H 3,2-G1 H 3 Bi
 279. 3-Ph H 2,3-G1 H 3 Bi
 280. 3-Ph H 3,2-G1 H 3 Bi
 281. 3-Ph H 2,3-G1 H 3 Bi
 282. 4-Ph H 3,2-G1 H 3 Bi
 283. H H 2,3-G2 H 3 Bi
 284. H H 3,2-G2 H 3 Bi
 285. 3-Ph H 2,3-G2 H 3 Bi
 286. 3-Ph H 3,2-G2 H 3 Bi
 287. 3-Ph H 2,3-G2 H 3 Bi
 288. 4-Ph H 3,2-G2 H 3 Bi
 289. H H 2,3-G3 H 3 Bi
 290. H H 3,2-G3 H 3 Bi
 291. 3-Ph H 2,3-G3 H 3 Bi
 292. 3-Ph H 3,2-G3 H 3 Bi
 293. 3-Ph H 2,3-G3 H 3 Bi
 294. 4-Ph H 3,2-G3 H 3 Bi No. R^(A) R¹ R² R³/R⁴ n M
 295. H H H 3,4-G1 3 Bi
 296. H H H 4,3-G1 3 Bi
 297. 3-Ph H H 3,4-G1 3 Bi
 298. 3-Ph H H 4,3-G1 3 Bi
 299. 3-Ph H H 3,4-G1 3 Bi
 300. H H H 4,3-G1 3 Bi
 301. H H H 3,4-G2 3 Bi
 302. 3-Ph H H 4,3-G2 3 Bi
 303. 3-Ph H H 3,4-G2 3 Bi
 304. 3-Ph H H 4,3-G2 3 Bi
 305. 4-Ph H H 3,4-G2 3 Bi
 306. H H H 4,3-G2 3 Bi
 307. H H H 3,4-G3 3 Bi
 308. 3-Ph H H 4,3-G3 3 Bi
 309. 3-Ph H H 3,4-G3 3 Bi
 310. 3-Ph H H 4,3-G3 3 Bi
 311. 4-Ph H H 3,4-G3 3 Bi
 312. H H H 4,3-G3 3 Bi No. R^(A) R¹/R² R³ R⁴ n M
 313. H 1,2-G4 H H 2 Zn
 314. 3-Ph 1,2-G4 H H 2 Zn
 315. 4-Ph 1.2-G4 H H 2 Zn
 316. H 2,1-G4 H H 2 Zn
 317. 3-Ph 2,1-G4 H H 2 Zn
 318. 4-Ph 2,1-G4 H H 2 Zn
 319. H 1,2-G5 H H 2 Zn
 320. 3-Ph 1,2-G5 H H 2 Zn
 321. 4-Ph 1,2-G5 H H 2 Zn
 322. H 2,1-G5 H H 2 Zn
 323. 3-Ph 2,1-G5 H H 2 Zn
 324. 4-Ph 2,1-G5 H H 2 Zn
 325. H 1,2-G6 H H 2 Zn
 326. 3-Ph 1,2-G6 H H 2 Zn
 327. 4-Ph 1,2-G6 H H 2 Zn
 328. H 2,1-G6 H H 2 Zn
 329. 3-Ph 2,1-G6 H H 2 Zn
 330. 4-Ph 2,1-G6 H H 2 Zn
 331. H 1,2-G7 H H 2 Zn
 332. 3-Ph 1,2-G7 H H 2 Zn
 333. 4-Ph 1,2-G7 H H 2 Zn
 334. H 2,1-G7 H H 2 Zn
 335. 3-Ph 2,1-G7 H H 2 Zn
 336. 4-Ph 2,1-G7 H H 2 Zn
 337. H 1,2-G8 H H 2 Zn
 338. 3-Ph 1,2-G8 H H 2 Zn
 339. 4-Ph 1,2-G8 H H 2 Zn
 340. H 2,1-G8 H H 2 Zn
 341. 3-Ph 2,1-G8 H H 2 Zn
 342. 4-Ph 2,1-G8 H H 2 Zn
 343. H 1,2-G9 H H 2 Zn
 344. 3-Ph 1,2-G9 H H 2 Zn
 345. 4-Ph 1,2-G9 H H 2 Zn
 346. H 2,1-G9 H H 2 Zn
 347. 3-Ph 2,1-G9 H H 2 Zn
 348. 4-Ph 2,1-G9 H H 2 Zn
 349. H 1,2-G10 H H 2 Zn
 350. 3-Ph 1,2-G10 H H 2 Zn
 351. 4-Ph 1,2-G10 H H 2 Zn
 352. H 2,1-G10 H H 2 Zn
 353. 3-Ph 2,1-G10 H H 2 Zn
 354. 4-Ph 2,1-G10 H H 2 Zn
 355. H 1,2-G11 H H 2 Zn
 356. 3-Ph 1,2-G11 H H 2 Zn
 357. 4-Ph 1,2-G11 H H 2 Zn
 358. H 2,1-G11 H H 2 Zn
 359. 3-Ph 2,1-G11 H H 2 Zn
 360. 4-Ph 2,1-G11 H H 2 Zn
 361. H 1,2-G12 H H 2 Zn
 362. 3-Ph 1,2-G12 H H 2 Zn
 363. 4-Ph 1,2-G12 H H 2 Zn
 364. H 2,1-G12 H H 2 Zn
 365. 3-Ph 2,1-G12 H H 2 Zn
 366. 4-Ph 2,1-G12 H H 2 Zn
 367. H 1,2-G13 H H 2 Zn
 368. H 1,2-G14 H H 2 Zn
 369. H 2,1-G13 H H 2 Zn
 370. H 2,1-G14 H H 2 Zn No. R^(A) R¹ R²/R³ R⁴ n M
 371. H H 2,3-G4 H 2 Zn
 372. 3-Ph H 2,3-G4 H 2 Zn
 373. 4-Ph H 2,3-G4 H 2 Zn
 374. H H 3,2-G4 H 2 Zn
 375. 3-Ph H 3,2-G4 H 2 Zn
 376. 4-Ph H 3,2-G4 H 2 Zn
 377. H H 2,3-G5 H 2 Zn
 378. 3-Ph H 2,3-G5 H 2 Zn
 379. 4-Ph H 2,3-G5 H 2 Zn
 380. H H 3,2-G5 H 2 Zn
 381. 3-Ph H 3,2-G5 H 2 Zn
 382. 4-Ph H 3,2-G5 H 2 Zn
 383. H H 2,3-G6 H 2 Zn
 384. 3-Ph H 2,3-G6 H 2 Zn
 385. 4-Ph H 2,3-G6 H 2 Zn
 386. H H 3,2-G6 H 2 Zn
 387. 3-Ph H 3,2-G6 H 2 Zn
 388. 4-Ph H 3,2-G6 H 2 Zn
 389. H H 2,3-G7 H 2 Zn
 390. 3-Ph H 2,3-G7 H 2 Zn
 391. 4-Ph H 2,3-G7 H 2 Zn
 392. H H 3,2-G7 H 2 Zn
 393. 3-Ph H 3,2-G7 H 2 Zn
 394. 4-Ph H 3,2-G7 H 2 Zn
 395. H H 2,3-G8 H 2 Zn
 396. 3-Ph H 2,3-G8 H 2 Zn
 397. 4-Ph H 2,3-G8 H 2 Zn
 398. H H 3,2-G8 H 2 Zn
 399. 3-Ph H 3,2-G8 H 2 Zn 400 4-Ph H 3,2-G8 H 2 Zn
 401. H H 2,3-G9 H 2 Zn
 402. 3-Ph H 2,3-G9 H 2 Zn
 403. 4-Ph H 2,3-G9 H 2 Zn
 404. H H 3,2-G9 H 2 Zn
 405. 3-Ph H 3,2-G9 H 2 Zn
 406. 4-Ph H 3,2-G9 H 2 Zn
 407. H H 2,3-G10 H 2 Zn
 408. 3-Ph H 2,3-G10 H 2 Zn
 409. 4-Ph H 2,3-G10 H 2 Zn 410 H H 3,2-G10 H 2 Zn
 411. 3-Ph H 3,2-G10 H 2 Zn
 412. 4-Ph H 3,2-G10 H 2 Zn
 413. H H 2,3-G11 H 2 Zn
 414. 3-Ph H 2,3-G11 H 2 Zn
 415. 4-Ph H 2,3-G11 H 2 Zn
 416. H H 3,2-G11 H 2 Zn
 417. 3-Ph H 3,2-G11 H 2 Zn
 418. 4-Ph H 3,2-G11 H 2 Zn
 419. H H 2,3-G12 H 2 Zn
 420. 3-Ph H 2,3-G12 H 2 Zn
 421. 4-Ph H 2,3-G12 H 2 Zn
 422. H H 3,2-G12 H 2 Zn
 423. 3-Ph H 3,2-G12 H 2 Zn
 424. 4-Ph H 3,2-G12 H 2 Zn
 425. H H 2,3-G13 H 2 Zn
 426. H H 2,3-G14 H 2 Zn
 427. H H 3,2-G13 H 2 Zn
 428. H H 3,2-G14 H 2 Zn

wherein the ring group of G1 to G14 are defined as follows:


15. The compound of claim 1, wherein m is 1 or 2, and the ligand L_(c) is independently selected from the group consisting of;

wherein R^(A), R^(B), and R^(C) represent from mono substitution to the possible maximum number of substitution, or no substitution; and R_(a), R_(b), and R_(c) are are independently hydrogen or a substituent selected from the group consisting of deuterium, halide, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, nitrile, isonitrile, phosphino, sulfanyl, and any combination of substituents thereof; or any two adjacent R_(a), R_(b), and R_(c) can join to form an aliphatic, aryl or heteroaryl ring, which is optionally substituted.
 16. An organic light emitting device (OLED) comprising: an anode; a cathode; and an organic layer disposed between the anode and the cathode, the organic layer including a compound of Formula (L_(A))_(n)-M-(L_(C))_(m); wherein the ligand L_(A) is of Formula I, and ligand L_(C) is selected from Formula I that is different than ligand L_(A), a monoanionic bidentate ligand, or monodentate ligand, M is a metal, and n is 1 or 2, and m is 0, 1 or 2;

wherein Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B; Z is selected from O or S; Z¹ is selected from a carbene C or N; and Z² is selected from C or N; R^(A) and R^(B) represent mono to the maximum allowable substitution, or no substitution; each R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent groups of R^(A) or R^(B) can join to form a carbocyclic ring or a heterocyclic ring, which is optionally substituted; or optionally R^(A) or R^(B) can join with the ligand L_(C) to form a multidentate ligand; with the proviso that two adjacent ring carbons of Ring B form a group of formula D, wherein * represents the point of attachment to the two adjacent ring carbons,

wherein X is selected from NR^(N), O, S, or Se; Y¹, Y², Y³, and Y⁴ are independently CR^(Y1), CR^(Y2), CR^(Y3), and CR^(Y4), respectively, or N, and Ring D has no more than two nitrogen ring atoms; R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently selected from the group hydrogen, deuterium, fluorine, alkyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, acyl, ester, nitrile, isonitrile, sulfanyl, and combinations thereof; or any two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can join to form a fused 6-member ring, or a fused 5-member ring, each of which can be carbocyclic or heterocyclic, and aromatic or non-aromatic, each of which is optionally substituted.
 17. The OLED of claim 16, wherein the compounds of Formula I are present as a co-host material in the organic layer.
 18. The OLED of claim 16, wherein the organic layer further comprises a co-host material selected from the group consisting of;


19. A consumer product that includes an organic light-emitting device (OLED), the OLED including an anode; a cathode; and an organic layer disposed between the anode and the cathode, the organic layer including a compound of Formula (L_(A))_(n)-M-(L_(C))_(m); wherein ligand L_(A) is of Formula I, and ligand L_(C) is selected from Formula I that is different than the ligand L_(A), a monoanionic bidentate ligand, or monodentate ligand, M is a metal, and n is 1 or 2, and m is 0, 1 or 2;

wherein Ring A is a 5-membered or 6-membered heteroaryl ring, which is bonded to Ring B; Z is selected from O or S; Z¹ is selected from a carbene C or N; and Z² is selected from C or N; R^(A) and R^(B) represent mono to the maximum allowable substitution, or no substitution; each R^(A) and R^(B) are independently hydrogen or a substituent selected from the group consisting of deuterium, halogen, alkyl, cycloalkyl, heteroalkyl, heterocycloalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carboxylic acid, ether, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; or optionally, any two adjacent groups of R^(A) or R^(B) can join to form a carbocyclic ring or a heterocyclic ring, which is optionally substituted; or optionally R^(A) or R^(B) can join with the ligand L_(C) to form a multidentate ligand; with the proviso that two adjacent ring carbons of Ring B form a group of Formula D, wherein * represents the point of attachment to the two adjacent ring carbons,

wherein X is selected from NR^(N), O, S, or Se; Y¹, Y², Y³, and Y⁴ are independently CR^(Y1), CR^(Y2), CR^(Y3), and CR^(Y4), respectively, or N, and Ring D has no more than two nitrogen ring atoms; R^(Y1), R^(Y2), R^(Y3), and R^(Y4) are independently selected from the group hydrogen, deuterium, fluorine, alkyl, cycloalkyl, cycloalkenyl, heteroalkyl, heteroalkenyl, alkoxy, aryloxy, amino, silyl, aryl, heteroaryl, acyl, ester, nitrile, isonitrile, sulfanyl, and combinations thereof; or any two adjacent R^(Y1), R^(Y2), R^(Y3), and R^(Y4) can join to form a fused 6-member ring, or a fused 5-member ring, each of which can be carbocyclic or heterocyclic, and aromatic or non-aromatic, each of which is optionally substituted.
 20. A formulation comprising a compound of claim
 1. 